title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
Catalent  ( NYSE:CTLT )  Upgraded at StockNews.com,https://www.defenseworld.net/2024/01/28/catalent-nysectlt-upgraded-at-stocknews-com.html,2024-01-28 09:30:46,StockNews.com upgraded shares of Catalent ( NYSE:CTLT - Free Report ) to a sell rating in a research note published on Thursday morning. Other equities research analysts have also issued research reports about the company. Robert W.,CTLT,0.822984,0.393747,Bullish
Softgel Capsules Market to Hit US$ 932.1 Million by 2033 | Updated Insights Report by Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36692438/softgel-capsules-market-to-hit-us-932-1-million-by-2033-updated-insights-report-by-persistence-mar,2024-01-19 11:30:00,"New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Softgel capsules have been crafted using gelatin as the primary raw material.",CTLT,0.055364,0.159126,Somewhat-Bullish
Is Invesco S&P 500 Equal Weight Health Care ETF  ( RSPH )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2210508/is-invesco-sp-500-equal-weight-health-care-etf-rsph-a-strong-etf-right-now,2024-01-16 11:20:06,Smart Beta ETF report for ...,CTLT,0.121959,0.062526,Neutral
These 9 Stocks Are Running To Start 2024,https://www.investors.com/news/sp-500-these-9-stocks-are-running-to-start-2024/,2024-01-14 13:00:00,"The S&P 500 index is up just a fraction in 2024 so far, but a number of big caps are off to a strong start. Nvidia ( NVDA ) , the No. 1 S&P 500 stock performer in 2023, is leading the way again. That is, excluding Juniper Networks ( JNPR ) , which spiked last week as Hewlett Packard Enterprise ( ...",CTLT,0.213048,0.149398,Neutral
60% Of This Year's Top Stocks Are In This Sector  ( It's Not Tech ) ,https://www.investors.com/etfs-and-funds/etfs/sp500-this-years-top-stocks-are-in-this-sector-not-tech/,2024-01-11 13:00:00,"Just when it looked like technology stocks took over the S&P 500 - another sector is on the rise. Health care stocks, like Viatris ( VTRS ) , Catalent ( CTLT ) and Moderna ( MRNA ) , are dominating the ranks of top-performing stocks this year so far, says an Investor's Business Daily analysis of ...",CTLT,0.123209,0.192664,Somewhat-Bullish
Catalent  ( NYSE:CTLT )  Upgraded to Sell by StockNews.com,https://www.defenseworld.net/2024/01/10/catalent-nysectlt-upgraded-to-sell-by-stocknews-com-2.html,2024-01-10 07:56:48,StockNews.com upgraded shares of Catalent ( NYSE:CTLT - Free Report ) to a sell rating in a report published on Tuesday morning.,CTLT,0.902661,0.394191,Bullish
"Stock Market News for Jan 8, 2024",https://www.zacks.com/stock/news/2206898/stock-market-news-for-jan-8-2024,2024-01-08 14:10:00,Wall Street closed higher after a choppy session on Friday to finish the first week of 2024.,CTLT,0.112008,0.142413,Neutral
"NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO",https://www.globenewswire.com/news-release/2024/01/08/2805449/32418/en/NightHawk-Biosciences-Announces-Planned-Name-Change-to-Scorpius-Holdings-Reflecting-Successful-Transition-to-a-Large-Molecule-Biomanufacturing-CDMO.html,2024-01-08 13:30:00,Announces senior leadership appointments to further support client programs and growing sales pipeline Announces senior leadership appointments to further support client programs and growing sales pipeline ...,CTLT,0.031241,0.027119,Neutral
Recursion Pharmaceuticals  ( RXRX )  Soars 7.4%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2206827/recursion-pharmaceuticals-rxrx-soars-74-is-further-upside-left-in-the-stock,2024-01-08 13:23:00,Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.,CTLT,0.551295,0.0,Neutral
"12 Stocks Turn $10,000 Into $320,800 In 12 Months",https://www.investors.com/etfs-and-funds/sectors/sp500-12-stocks-turn-10000-into-in-12-months-2023/,2023-12-29 13:00:00,Talk about a strong finish. Investors who hung onto the top S&P 500 stocks this year ended up much richer for the effort.,CTLT,0.092569,0.16205,Somewhat-Bullish
What Happened With Caltalent Stock? - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/news/23/12/36313826/what-happened-with-caltalent-stock,2023-12-19 21:12:16,"Catalent, Inc. CTLT shares traded higher on Tuesday. Following losses at the end of October, the stock has rebounded over the past month. What To Know: From the middle of October until the beginning of November, Catalent shares slid considerably.",CTLT,0.891977,0.539297,Bullish
Clinical Trial Supplies Market is Expected to Reach $6.3 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/12/g36300694/clinical-trial-supplies-market-is-expected-to-reach-6-3-billion-marketsandmarkets,2023-12-19 12:30:00,"Chicago, Dec. 19, 2023 ( GLOBE NEWSWIRE ) -- Clinical Trial Supplies market in terms of revenue was estimated to be worth $3.9 Billion in 2023 and is poised to reach $6.3 billion by 2028, growing at a CAGR of 9.9% from 2023 to 2028 according to a latest report published by MarketsandMarketsâ„¢.",CTLT,0.033942,0.007604,Neutral
Catalent  ( CTLT )  Up 4.1% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2198839/catalent-ctlt-up-41-since-last-earnings-report-can-it-continue,2023-12-15 16:30:10,Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,CTLT,0.384397,0.080285,Neutral
Here's Why You Should Retain Catalent  ( CTLT )  Stock for Now,https://www.zacks.com/stock/news/2198761/heres-why-you-should-retain-catalent-ctlt-stock-for-now,2023-12-15 15:17:00,Catalent's (CTLT) products and services portfolio and technology foundation raise optimism about the stock.,CTLT,0.350564,0.270521,Somewhat-Bullish
Is SPDR S&P Pharmaceuticals ETF  ( XPH )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2198396/is-spdr-sp-pharmaceuticals-etf-xph-a-strong-etf-right-now,2023-12-15 11:20:03,Smart Beta ETF report for ...,CTLT,0.112797,0.053966,Neutral
Should You Invest in the SPDR S&P Pharmaceuticals ETF  ( XPH ) ?,https://www.zacks.com/stock/news/2197719/should-you-invest-in-the-spdr-sp-pharmaceuticals-etf-xph,2023-12-14 11:20:02,Sector ETF report for ...,CTLT,0.125789,0.059923,Neutral
"Catalent  ( NYSE:CTLT )  Upgraded to ""Sell"" by StockNews.com",https://www.defenseworld.net/2023/12/09/catalent-nysectlt-upgraded-to-sell-by-stocknews-com.html,2023-12-10 02:07:49,StockNews.com upgraded shares of Catalent ( NYSE:CTLT - Free Report ) to a sell rating in a research report released on Friday. A number of other equities research analysts have also issued reports on the company.,CTLT,0.851762,0.489507,Bullish
"Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality' - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/11/36016776/jim-cramer-buy-this-financial-stock-i-think-theyre-high-quality,2023-11-30 14:26:54,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Vishay Intertechnology, Inc. VSH is ""way too cheap."" He added, ""This is one of those moments where I think you've got to buy Vishay."" Cramer also recommended buying Abbott Laboratories ABT. ""Abbot Labs has gotten way too cheap,"" he noted.",CTLT,0.468029,0.288239,Somewhat-Bullish
"11 Stocks Turn $10,000 Into $230,769 In 11 Months",https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-turn-10000-into-in-11-months/,2023-11-30 13:00:00,Hope you didn't bail out of S&P 500 stocks after three straight months of losses. November turned into a big moneymaker for patient investors.,CTLT,0.099683,0.108654,Neutral
The TIM Company Appoints Biotech Veteran Dr. Behzad Mahdavi as Transformative CEO and Board Member - PR Newswire,https://www.prnewswire.com/news-releases/the-tim-company-appoints-biotech-veteran-dr-behzad-mahdavi-as-transformative-ceo-and-board-member-301998772.html,2023-11-28 13:44:00,The TIM Company Appoints Biotech Veteran Dr. Behzad Mahdavi as Transformative CEO and Board Member PR ...,CTLT,0.061159,0.281322,Somewhat-Bullish
CTLT: Catalent  ( CTLT )  Loses 6.1% Over the Past Month: Can the Stock Reverse Its Fortune?,https://stocknews.com/news/ctlt-snphy-taro-abbv-catalent-ctlt-loses-6-1-over-the-past-month-can-the/,2023-11-24 16:11:08,CTLT: Catalent ( CTLT ) Loses 6.1% Over the Past Month: Can the ... ...,CTLT,0.63414,0.115384,Neutral
Biopharmaceutical Analytical Testing Services Market to grow by USD 3.45 billion from 2022 to 2027; North America to ... - PR Newswire,https://www.prnewswire.com/news-releases/biopharmaceutical-analytical-testing-services-market-to-grow-by-usd-3-45-billion-from-2022-to-2027-north-america-to-account-for-33-of-market-growth--technavio-301993507.html,2023-11-21 18:00:00,Biopharmaceutical Analytical Testing Services Market to grow by USD 3.45 billion from 2022 to 2027. North America to ... PR ...,CTLT,0.140485,0.101355,Neutral
StockNews.com Upgrades Catalent  ( NYSE:CTLT )  to Sell,https://www.defenseworld.net/2023/11/18/stocknews-com-upgrades-catalent-nysectlt-to-sell-2.html,2023-11-18 06:22:47,"Catalent ( NYSE:CTLT - Get Free Report ) was upgraded by analysts at StockNews.com to a ""sell"" rating in a report issued on Thursday. CTLT has been the subject of several other reports.",CTLT,0.754316,0.37686,Bullish
Exclusive: Manufacturer Lonza says it will not fill obesity drug syringes,https://www.reuters.com/business/healthcare-pharmaceuticals/manufacturer-lonza-says-it-will-not-fill-obesity-drug-syringes-2023-11-17/,2023-11-17 13:49:00,"The logo of Swiss contract drug maker Lonza is seen at its headquarters in Basel, Switzerland October 1, 2020. REUTERS/Arnd Wiegmann/File Photo Acquire Licensing Rights",CTLT,0.056143,0.18296,Somewhat-Bullish
Catalent  ( CTLT )  Preliminary Q1 Revenues Dampened by Lower Sales,https://www.zacks.com/stock/news/2185238/catalent-ctlt-preliminary-q1-revenues-dampened-by-lower-sales,2023-11-16 13:58:00,"Catalent (CTLT) records lower revenues in Biologics segments in its first-quarter fiscal 2024, resulting in overall soft preliminary performance.",CTLT,0.348715,-0.23171,Somewhat-Bearish
"Stock Market News for Nov 16, 2023",https://www.zacks.com/stock/news/2185180/stock-market-news-for-nov-16-2023,2023-11-16 13:16:00,Wall Street closed higher on Wednesday after a sharp rally in the previous day.,CTLT,0.198493,-0.006483,Neutral
Catalent  ( CTLT )  Up on Encouraging Pre-Filled Syringe Potential,https://www.zacks.com/stock/news/2185177/catalent-ctlt-up-on-encouraging-pre-filled-syringe-potential,2023-11-16 13:12:00,Catalent (CTLT) expects the demand for its pre-filled syringes to improve going forward. The company anticipates the majority of its pre-filled syringe production capacity to be booked until fiscal 2026.,CTLT,0.699089,0.427335,Bullish
"Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday - Advance Auto Parts  ( NYSE:AAP ) , Alcon  ( NYSE:ALC ) ",https://www.benzinga.com/news/23/11/35825394/intel-to-rally-over-23-here-are-10-top-analyst-forecasts-for-thursday,2023-11-16 13:07:18,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Raymond James cut Global-e Online Ltd. GLBE price target from $45 to $41.",CTLT,0.238913,0.393275,Bullish
Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/11/35809119/catalents-q1-performance-beat-expectations-analyst-says-main-focus-on-manufacturing,2023-11-15 19:26:48,"Catalent Inc's CTLT Q1 FY24 revenue of $982 million decreased 4% as reported, or 6%, in constant currency, beating the consensus of $939.14 million. Overall, organic net revenue decreased by 8% over the same period. Q1 24 net loss of $ ( 715 ) million includes non-cash goodwill impairment ...",CTLT,0.716023,0.339046,Somewhat-Bullish
"Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday - American Eagle Outfitters  ( NYSE:AEO ) , Arcturus Therapeutics  ( NASDAQ:ARCT ) ",https://www.benzinga.com/news/23/11/35807854/target-reports-earnings-beat-joins-ast-spacemobile-dada-nexus-and-other-big-stocks-moving-higher-on,2023-11-15 16:08:03,"U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation TGT jumped during Wednesday's session after the company reported better-than-expected third-quarter financial results.",CTLT,0.190417,0.360834,Bullish
Catalent beats quarterly revenue estimates,https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-beats-quarterly-revenue-estimates-2023-11-15/,2023-11-15 12:15:00,"A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing Rights",CTLT,0.617765,0.049579,Neutral
"US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/11/35800999/us-stocks-on-track-to-build-on-gains-as-traders-await-a-batch-of-data-can-market-resist-profit-taki,2023-11-15 12:09:06,"U.S. stocks could build on the momentum they picked up on Tuesday following the release of benign inflation data. Traders get to digest another batch of economic data on producer price inflation, retail sales, regional manufacturing activity, and a few speeches by Federal Reserve officials.",CTLT,0.07913,0.0,Neutral
Catalent delays quarterly filing with SEC on $700 mln impairment charge,https://www.reuters.com/business/catalent-delays-quarterly-filing-with-sec-700-mln-impairment-charge-2023-11-14/,2023-11-14 10:56:00,"A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman Acquire Licensing Rights",CTLT,0.686739,-0.037779,Neutral
Catalent  ( CTLT )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2183176/catalent-ctlt-to-report-q1-earnings-whats-in-the-cards,2023-11-13 13:39:00,Catalent's (CTLT) fiscal Q1 results are likely to be affected by soft performance by the Biologics segment.,CTLT,0.242406,0.13486,Neutral
"Sotera Health Appoints Karen Flynn to Board of Directors - Catalent  ( NYSE:CTLT ) , Quanterix  ( NASDAQ:QTRX ) ",https://www.benzinga.com/pressreleases/23/11/g35744863/sotera-health-appoints-karen-flynn-to-board-of-directors,2023-11-13 12:00:14,"CLEVELAND, Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Sotera Health Company SHC, a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Karen Flynn as a new independent director ...",CTLT,0.443626,0.09249,Neutral
Sotera Health Appoints Karen Flynn to Board of Directors,https://www.globenewswire.com/news-release/2023/11/13/2778909/0/en/Sotera-Health-Appoints-Karen-Flynn-to-Board-of-Directors.html,2023-11-13 12:00:00,"CLEVELAND, Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Sotera Health Company ( Nasdaq: SHC ) , a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Karen Flynn as a new ...",CTLT,0.469744,0.096051,Neutral
Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 to 2027 | The growth of the biopharmaceutical ... - PR Newswire,https://www.prnewswire.com/news-releases/clinical-trial-supplies-market-to-grow-by-usd-1-19-billion-from-2022-to-2027--the-growth-of-the-biopharmaceutical-industry-drives-the-market-growth---technavio-301984313.html,2023-11-13 03:00:00,Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 to 2027 | The growth of the biopharmaceutical ... PR ...,CTLT,0.044304,0.0,Neutral
Adult Vitamin Gummies Market to grow by USD 2.75 billion from 2023-2028; North America to account for 41% of ... - PR Newswire,https://www.prnewswire.com/news-releases/adult-vitamin-gummies-market-to-grow-by-usd-2-75-billion-from-2023-2028-north-america-to-account-for-41-of-market-growth---technavio-301984277.html,2023-11-10 22:15:00,Adult Vitamin Gummies Market to grow by USD 2.75 billion from 2023-2028. North America to account for 41% of ... PR ...,CTLT,0.061949,0.11403,Neutral
Cell and Gene Therapy Manufacturing Market to Achieve a Valuation of USD 8.8 billion by 2031| Analysis by Transparency Market Research,https://www.benzinga.com/pressreleases/23/11/g35699021/cell-and-gene-therapy-manufacturing-market-to-achieve-a-valuation-of-usd-8-8-billion-by-2031-analy,2023-11-09 13:30:00,"Wilmington, Delaware, United States, Nov. 09, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global cell and gene therapy manufacturing market is projected to flourish at a CAGR of 25.2% from 2023 to 2031.",CTLT,0.039811,0.058848,Neutral
Biotech Stock Surges As Activist Reportedly Builds $1 Billion Stake,https://www.investors.com/news/technology/bmrn-stock-rockets-as-activist-investor-reportedly-builds-stake/,2023-11-07 19:16:00,BMRN Stock Rockets As Activist Investor Reportedly Builds $1 ... Investor's Business Daily ...,CTLT,0.201244,0.178521,Somewhat-Bullish
"Fusion Pharmaceuticals Inc.  ( FUSN )  Reports Q3 Loss, Tops Revenue Estimates",https://www.zacks.com/stock/news/2179907/fusion-pharmaceuticals-inc-fusn-reports-q3-loss-tops-revenue-estimates,2023-11-07 13:25:06,"Fusion Pharmaceuticals Inc. (FUSN) delivered earnings and revenue surprises of 37.50% and 389.27%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.137671,0.0,Neutral
"StockNews.com Upgrades Catalent  ( NYSE:CTLT )  to ""Sell""",https://www.defenseworld.net/2023/11/05/stocknews-com-upgrades-catalent-nysectlt-to-sell.html,2023-11-05 08:50:42,"Catalent ( NYSE:CTLT - Get Free Report ) was upgraded by StockNews.com to a ""sell"" rating in a note issued to investors on Friday.",CTLT,0.730828,0.450537,Bullish
"Carbon Revolution plc Begins Trading Today on Nasdaq Under the Symbol ""CREV""",https://www.globenewswire.com/news-release/2023/11/03/2773045/0/en/Carbon-Revolution-plc-Begins-Trading-Today-on-Nasdaq-Under-the-Symbol-CREV.html,2023-11-03 10:30:00,"GEELONG, Australia, Nov. 03, 2023 ( GLOBE NEWSWIRE ) -- Carbon Revolution plc, parent of Carbon Revolution Limited ( the ""Company"" or ""Carbon Revolution"" ) , a Tier 1 OEM supplier and a leading global manufacturer of lightweight advanced technology carbon fiber wheels, announced that its stock ...",CTLT,0.022038,-0.077067,Neutral
"Carbon Revolution plc Begins Trading Today on Nasdaq Under the Symbol ""CREV""",https://www.benzinga.com/pressreleases/23/11/g35586511/carbon-revolution-plc-begins-trading-today-on-nasdaq-under-the-symbol-crev,2023-11-03 10:30:00,"GEELONG, Australia, Nov. 03, 2023 ( GLOBE NEWSWIRE ) -- Carbon Revolution plc, parent of Carbon Revolution Limited ( the ""Company"" or ""Carbon Revolution"" ) , a Tier 1 OEM supplier and a leading global manufacturer of lightweight advanced technology carbon fiber wheels, announced that its stock ...",CTLT,0.021937,-0.016373,Neutral
"Novo Nordisk adding in-house fill-finish capacity for Wegovy's European pen, Ozempic",https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-adding-in-house-fill-finish-capacity-wegovys-european-pen-ozempic-2023-11-02/,2023-11-02 12:08:00,"Novo Nordisk adding in-house fill-finish capacity for Wegovy's European pen, ...",CTLT,0.068502,-0.030576,Neutral
Exclusive: Novo hires FUJIFILM unit to help make Wegovy weight-loss drug - source,https://www.reuters.com/business/healthcare-pharmaceuticals/novo-hires-fujifilm-unit-help-make-wegovy-weight-loss-drug-source-2023-11-01/,2023-11-01 17:14:00,"A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",CTLT,0.112008,-0.014613,Neutral
Looking At Catalent's Recent Unusual Options Activity - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/markets/options/23/11/35542097/looking-at-catalents-recent-unusual-options-activity,2023-11-01 16:01:01,"Someone with a lot of money to spend has taken a bearish stance on Catalent CTLT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",CTLT,0.765213,0.28596,Somewhat-Bullish
How Novo Nordisk makes its weight-loss drug Wegovy,https://www.reuters.com/business/healthcare-pharmaceuticals/how-novo-nordisk-makes-its-weight-loss-drug-wegovy-2023-11-01/,2023-11-01 10:17:00,How Novo Nordisk makes its weight-loss drug ...,CTLT,0.082111,0.0,Neutral
Wall Street closes higher on eve of Fed decision; investors assess earnings,https://www.moneycontrol.com/news/business/markets/wall-street-closes-higher-on-eve-of-fed-decision-investors-assess-earnings-11637681.html,2023-11-01 00:54:42,"The Fed kicked off a two-day monetary policy meeting. The central bank is widely expected to hold interest rates steady on Wednesday, and investors will monitor its statement and Fed Chair Jerome Powell's comments for clues about its plans.",CTLT,0.049526,-0.142422,Neutral
What's Going On With Biotech Contract Service Firm Catalent Stock Today? - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35521160/whats-going-on-with-biotech-contract-service-firm-catalent-stock-today,2023-10-31 19:03:23,"Catalent Inc CTLT shares are trading lower due to its significant exposure to Sarepta Therapeutics Inc SRPT on the back of disappointing data from a pivotal gene therapy trial. According to William Blair, Sarepta accounted for nearly 10% of total revenue and roughly 30% of non-COVID biologics ...",CTLT,0.716023,0.259763,Somewhat-Bullish
Earnings Preview: Catalent  ( CTLT )  Q1 Earnings Expected to Decline,https://www.zacks.com/stock/news/2175552/earnings-preview-catalent-ctlt-q1-earnings-expected-to-decline,2023-10-31 14:01:29,Catalent (CTLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,CTLT,0.262994,0.07979,Neutral
OpenCell Technologies Appoints Biotech Veteran Dr. Behzad Mahdavi as Executive Chairman of the Board of Directors - PR Newswire,https://www.prnewswire.com/news-releases/opencell-technologies-appoints-biotech-veteran-dr-behzad-mahdavi-as-executive-chairman-of-the-board-of-directors-301972270.html,2023-10-31 12:31:00,OpenCell Technologies Appoints Biotech Veteran Dr. Behzad Mahdavi as Executive Chairman of the Board of Directors PR ...,CTLT,0.075397,0.272934,Somewhat-Bullish
"10 Stocks Turn $10,000 Into $158,688 In 10 Months",https://www.investors.com/etfs-and-funds/sectors/sp500-10-stocks-turn-10000-into-in-10-months-2023/,2023-10-31 12:00:34,The S&P 500 just dropped for the third straight month - clobbering most S&P 500 investors. But there's still plenty of ways to profit amid the quicksand-like market.,CTLT,0.095517,0.096377,Neutral
Wall St eyes higher open as yields ease heading into Fed meet,https://www.reuters.com/markets/us/futures-mixed-after-previous-sessions-rally-fed-meet-focus-2023-10-31/,2023-10-31 11:20:00,"Futures rise heading into Fed meet, more earnings awaited ...",CTLT,0.071784,-0.302179,Somewhat-Bearish
"Phathom Pharmaceuticals Announces FDA Approval of Reformulated Vonoprazan Tablets for VOQUEZNAÂ® TRIPLE PAKÂ®  ( vonoprazan, amoxicillin, clarithromycin )  and VOQUEZNAÂ® DUAL PAKÂ®  ( vonoprazan, amoxicillin )  for the Treatment of H. pylori Infection in Adults",https://www.globenewswire.com/news-release/2023/10/30/2769171/0/en/Phathom-Pharmaceuticals-Announces-FDA-Approval-of-Reformulated-Vonoprazan-Tablets-for-VOQUEZNA-TRIPLE-PAK-vonoprazan-amoxicillin-clarithromycin-and-VOQUEZNA-DUAL-PAK-vonoprazan-amo.html,2023-10-30 12:00:00,"FLORHAM PARK, N.J., Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- Phathom Pharmaceuticals, Inc. ( Nasdaq: PHAT ) , a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal ( GI ) diseases, announced that the U.S.",CTLT,0.015904,0.02527,Neutral
Weight-loss drugs in spotlight as pharma services firms rush to snap up business,https://www.reuters.com/business/healthcare-pharmaceuticals/weight-loss-drugs-spotlight-pharma-services-firms-rush-snap-up-business-2023-10-27/,2023-10-27 10:26:00,"BARCELONA, Oct 27 ( Reuters ) - Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmaceutical services industry this week, as it fuels a boom for firms that fill and assemble the self-injection pens.",CTLT,0.055751,0.040904,Neutral
"Pharmaceutical packaging market size to grow by USD 48.88 billion from 2022 to 2027, North America to account for ... - PR Newswire",https://www.prnewswire.com/news-releases/pharmaceutical-packaging-market-size-to-grow-by-usd-48-88-billion-from-2022-to-2027--north-america-to-account-for-31-of-market-growth---technavio-301969565.html,2023-10-27 08:35:00,"Pharmaceutical packaging market size to grow by USD 48.88 billion from 2022 to 2027, North America to account for ... PR ...",CTLT,0.056808,0.0,Neutral
Novo investors seek clarity on Wegovy weight-loss drug shortages,https://www.reuters.com/business/healthcare-pharmaceuticals/novo-investors-seek-clarity-wegovy-weight-loss-drug-shortages-2023-10-27/,2023-10-27 05:59:24,"A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",CTLT,0.114409,0.025032,Neutral
"Why Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan",https://www.marketwatch.com/story/the-weight-loss-drugs-are-coming-for-these-companies-but-heres-why-coke-others-may-be-spared-says-jpmorgan-c6c24538,2023-10-24 10:42:00,"JPMorgan says the weight-loss drug industry is now a ""$100 billion plus opportunity."" Coke is one of the stocks they say is likely to get hit less hard.",CTLT,0.084722,0.067688,Neutral
Starboard may be poised to build value amicably at contract research firm Fortrea,https://www.cnbc.com/2023/10/21/starboard-may-be-poised-to-build-value-amicably-at-contract-research-firm-fortrea-.html,2023-10-21 10:36:39,Activist Starboard Value recently disclosed a position in Fortrea Holdings. The firm may be able to take a friendly approach to building shareholder value.,CTLT,0.053509,0.203791,Somewhat-Bullish
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/general/biotech/23/10/35142181/weight-loss-drug-boom-has-another-ripple-effect-rapid-growth-expected-in-fill-finish-market,2023-10-09 15:21:29,Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's NVO Wegovy.,CTLT,0.514619,0.32029,Somewhat-Bullish
Weight-loss drugs fuel boom for firms that fill syringes,https://www.reuters.com/business/healthcare-pharmaceuticals/weight-loss-drugs-fuel-boom-firms-that-fill-syringes-2023-10-09/,2023-10-09 05:15:08,"A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration//File Photo Acquire Licensing Rights",CTLT,0.168197,0.087607,Neutral
Revvity's  ( RVTY )  New Launch to Widen Access to Editing Technology,https://www.zacks.com/stock/news/2158739/revvitys-rvty-new-launch-to-widen-access-to-editing-technology,2023-10-02 14:10:00,Revvity's (RVTY) latest offering is likely to improve access to new-generation editing technology and bridge both preclinical and clinical discoveries with the same technology platform.,CTLT,0.177475,0.203957,Somewhat-Bullish
"9 Stocks Turn $10,000 Into $141,941 In 9 Months",https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-turn-10000-into-in-9-months-2023/,2023-09-29 12:00:00,Stocks tanked right on cue in September. But nimble S&P 500 investors are still finding ways to make big money as most others lose.,CTLT,0.095517,0.090344,Neutral
Catalent  ( CTLT )  Down 6.5% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2157209/catalent-ctlt-down-65-since-last-earnings-report-can-it-rebound,2023-09-28 15:30:11,Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,CTLT,0.436009,0.02639,Neutral
"Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer",https://www.benzinga.com/pressreleases/23/09/g34972851/cell-easy-is-pleased-to-welcome-mrs-gisele-deblandre-formerly-cso-at-masthercell-as-chief-scientif,2023-09-28 12:15:01,"TOULOUSE, France, Sept. 28, 2023 ( GLOBE NEWSWIRE ) -- Cell-Easy, a specialized contract development and manufacturing organization ( CDMO ) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre as the Chief Scientific Officer.",CTLT,0.062761,0.148103,Neutral
"CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/09/g34962393/catalent-alert-bragar-eagel-squire-p-c-is-investigating-catalent-inc-on-behalf-of-long-term-stockh,2023-09-28 01:00:00,"NEW YORK, Sept. 27, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc.",CTLT,0.657566,-0.275143,Somewhat-Bearish
3 Reasons to Hold Catalent  ( CTLT )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2156312/3-reasons-to-hold-catalent-ctlt-stock-in-your-portfolio,2023-09-27 14:59:00,Catalent's (CTLT) product and service launches and a slew of strategic deals raise optimism about the stock.,CTLT,0.415413,0.206729,Somewhat-Bullish
The disruptive effect of weight loss drugs like Ozempic could have surprising impacts on the stock market. Here are potential winners and losers.,https://markets.businessinsider.com/news/stocks/ozempic-wegovy-glp1-weight-loss-drugs-stock-market-winners-losers-2023-9,2023-09-24 12:30:00,Weight Loss Drugs Like Ozempic Could Have Surprising Stock Market Effects - Markets Insider ...,CTLT,0.038101,0.203966,Somewhat-Bullish
"CONTINUED INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Catalent, Inc.'s Directors and Officers for Breach of Fiduciary Duties - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/09/g34769368/continued-investigation-alert-scott-scott-attorneys-at-law-llp-investigates-catalent-inc-s-directo,2023-09-20 17:15:27,"NEW YORK, Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- Scott+Scott Attorneys at Law LLP ( ""Scott+Scott"" ) , an international securities and consumer rights litigation firm, continues investigating whether certain directors and officers of Catalent, Inc. ( ""Catalent"" and/or ""Company"" ) CTLT breached ...",CTLT,0.929556,0.038612,Neutral
Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 to 2027 | North America to account for 36% of ... - PR Newswire,https://www.prnewswire.com/news-releases/clinical-trial-supplies-market-to-grow-by-usd-1-19-billion-from-2022-to-2027--north-america-to-account-for-36-of-market-growth---technavio-301929305.html,2023-09-18 06:15:00,Clinical Trial Supplies Market to grow by USD 1.19 billion from 2022 to 2027 | North America to account for 36% of ... PR ...,CTLT,0.059488,0.0,Neutral
Activist Elliott makes inroads at Catalent to build value. Here's what could happen next,https://www.cnbc.com/2023/09/16/activist-elliott-makes-inroads-at-catalent-to-build-value-heres-what-could-happen-next.html,2023-09-16 12:35:55,Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical company.,CTLT,0.451494,0.28207,Somewhat-Bullish
Moderna to scale down manufacturing of COVID vaccine,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-scale-down-manufacturing-covid-vaccine-2023-09-13/,2023-09-13 10:42:00,"Sept 13 ( Reuters ) - Moderna ( MRNA.O ) on Wednesday announced it was scaling down manufacturing of its COVID-19 vaccine, an updated version of which was approved this week by U.S. regulators, to align with lower post-pandemic demand and help the company sooner hit its target of 75% to 80% ...",CTLT,0.085022,-0.107737,Neutral
Is Novo Nordisk Stock a Buy Now?,https://www.fool.com/investing/2023/09/07/is-novo-nordisk-stock-a-buy-now/,2023-09-07 14:07:00,Novo Nordisk recently launched Wegovy in the United Kingdom.,CTLT,0.061631,0.02213,Neutral
"Barron's Weekend Stock Picks: Globalstar Satellites, Catalent And Dell's Delightful Destiny - Catalent  ( NYSE:CTLT ) , Allegro Microsystems  ( NASDAQ:ALGM ) ",https://www.benzinga.com/news/23/09/34191084/barrons-weekend-stock-picks-globalstar-satellites-catalent-and-dells-delightful-destiny,2023-09-02 16:34:36,Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.,CTLT,0.382925,0.4623,Bullish
Why Catalent Stock Zoomed 12% Higher This Week,https://www.fool.com/investing/2023/09/01/why-catalent-stock-zoomed-12-higher-this-week/,2023-09-01 22:35:47,A strong earnings report and a clutch of analyst price target hikes will do that.,CTLT,0.541149,0.037037,Neutral
"8 Stocks Turn $10,000 Into $120,005 In 8 Months",https://www.investors.com/etfs-and-funds/sectors/sp500-8-stocks-turn-10000-into-more-in-8-months-2023/,2023-08-31 12:00:00,Some investors might be satisfied with a 5% risk-free return. But those who pick the right S&P 500 stocks are doing much better than that.,CTLT,0.112269,0.083665,Neutral
Catalent  ( CTLT )  Gains Post Deal With Elliott and Earnings Report,https://www.zacks.com/stock/news/2142620/catalent-ctlt-gains-post-deal-with-elliott-and-earnings-report,2023-08-30 17:28:00,Catalent's (CTLT) deal with Elliott and earnings report boost its shares. The company will likely improve its value and growth with the agreement and its strategic investments.,CTLT,0.517168,0.335605,Somewhat-Bullish
"Catalent's Activist Board Presence To Boost Operational Recovery, Analyst Says - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/08/34121149/catalents-activist-board-presence-to-boost-operational-recovery-analyst-says,2023-08-30 17:27:47,"Tuesday, Catalent Inc CTLT reported Q4 adjusted EPS of $0.09, missing the consensus of $0.10, with sales of $1.07 billion, down 17% Y/Y, slightly above the consensus of $1.05 billion. The company forecasts FY24 sales of $4.30 billion-$4.50 billion versus the consensus of $4.21 billion and $4.28 ...",CTLT,0.532941,0.287681,Somewhat-Bullish
"S&P 500 ends sharply higher, jobs data fuels interest rate optimism",https://www.moneycontrol.com/news/business/markets/sp-500-ends-sharply-higher-jobs-data-fuels-interest-rate-optimism-11280061.html,2023-08-30 00:40:19,"The SP 500 logged its strongest one-day gain since June 2, while the Nasdaq notched its strongest session since July 28, and both indexes closed at more than two-week highs.",CTLT,0.06515,0.065059,Neutral
Why Catalent Stock Surged Nearly 5% Higher Today,https://www.fool.com/investing/2023/08/29/why-catalent-stock-surged-nearly-5-higher-today/,2023-08-29 21:04:00,"Fourth-quarter performance that wasn't too disappointing, plus a settlement with an activist investor, brought some bulls back to the company's shares.",CTLT,0.705799,0.39751,Bullish
Catalent  ( CTLT )  Preliminary Q4 Revenues Dampened by Lower Sales,https://www.zacks.com/stock/news/2142102/catalent-ctlt-preliminary-q4-revenues-dampened-by-lower-sales,2023-08-29 17:48:00,"Catalent (CTLT) records lower revenues in Biologics segment in its fourth-quarter fiscal 2023, resulting in overall soft preliminary performance.",CTLT,0.42219,-0.057123,Neutral
"China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories - Best Buy Co  ( NYSE:BBY ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/08/34091008/chinas-response-to-shield-economy-from-real-estate-storm-biden-targets-cancer-diabetes-drugs-in-cont,2023-08-29 14:06:02,"China is pulling out all the stops in response to the brewing storm within its real estate sector, aiming to prevent the cascading impact from reaching other sectors and economies.",CTLT,0.121856,0.017437,Neutral
Catalent  ( CTLT )  Q4 Earnings Miss Estimates,https://www.zacks.com/stock/news/2141745/catalent-ctlt-q4-earnings-miss-estimates,2023-08-29 12:40:02,"Catalent (CTLT) delivered earnings and revenue surprises of -10% and 1.67%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.406745,0.115516,Neutral
"Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/general/biotech/23/08/34086113/beaten-down-covid-19-vaccine-partner-stock-catalent-finalizes-deal-with-activist-investor-reports,2023-08-29 12:17:43,"Catalent Inc CTLT, valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management. The board has recommended and approved the appointment of four new independent directors. With these appointments, Catalent's Board of Directors will consist of 16 directors, ...",CTLT,0.694939,0.082982,Neutral
Catalent reaches settlement with Elliot to explore strategic review,https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-revenue-falls-delays-annual-report-2023-08-29/,2023-08-29 11:14:00,"Catalent revenue falls, delays annual report ...",CTLT,0.646507,0.090618,Neutral
"Nasdaq, S&P 500 Futures Flatline Ahead Of JOLTS, House Price Data; Why This Analyst Recommends 'Buying Weakness Than Selling Rallies' - Alibaba Gr Holding  ( NYSE:BABA ) , XPeng  ( NYSE:XPEV ) , Big Lots  ( NYSE:BIG ) , PVH  ( NYSE:PVH ) , Baidu  ( NASDAQ:BIDU ) , HP  ( NYSE:HPQ ) , Box  ( NYSE:BOX ) , Donaldson  ( NYSE:DCI ) , Amgen  ( NASDAQ:AMGN ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , PDD Holdings  ( NASDAQ:PDD ) , Ambarella  ( NASDAQ:AMBA ) , NIO  ( NYSE:NIO ) , Horizon Therapeutics  ( NASDAQ:HZNP ) , JM Smucker  ( NYSE:SJM ) , Best Buy Co  ( NYSE:BBY ) , Hewlett Packard  ( NYSE:HPE ) , Hawaiian Electric Indus  ( NYSE:HE ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/08/34084194/nasdaq-s-p-500-futures-flatline-ahead-of-jolts-house-price-data-why-this-analyst-recommends-buying-,2023-08-29 10:16:49,"Sentiment going into Tuesday's session appears to be muted, as evident from the stock futures, which were narrowly mixed. A few key economic readings due for the day, including the house prices data, consumer confidence reading, and the JOLTS survey, could keep traders on tenterhooks, given the ...",CTLT,0.045224,0.0,Neutral
"CONTINUED INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Catalent, Inc.'s Directors and Officers for Breach of Fiduciary Duties - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/08/g34080402/continued-investigation-alert-scott-scott-attorneys-at-law-llp-investigates-catalent-inc-s-directo,2023-08-28 22:40:20,"NEW YORK, Aug. 28, 2023 ( GLOBE NEWSWIRE ) -- Scott+Scott Attorneys at Law LLP ( ""Scott+Scott"" ) , an international securities and consumer rights litigation firm, continues investigating whether certain directors and officers of Catalent, Inc. ( ""Catalent"" and/or ""Company"" ) CTLT breached their ...",CTLT,0.929556,0.038612,Neutral
Exclusive: Catalent nears settlement with Elliott for board seats -sources,https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-nears-settlement-with-elliott-board-seats-sources-2023-08-28/,2023-08-28 21:07:00,Exclusive: Catalent nears settlement with Elliott for board seats ...,CTLT,0.739411,0.140251,Neutral
"Unleashing Potential: AAV-Focused CDMO Market Propelled by 24.61% CAGR, Transforming Gene Therapies",https://www.prnewswire.com/news-releases/unleashing-potential-aav-focused-cdmo-market-propelled-by-24-61-cagr-transforming-gene-therapies-301910077.html,2023-08-26 02:00:00,"DUBLIN, Aug. 25, 2023 /PRNewswire/ -- The ""Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development, Workflow, Indication, Culture Type, and Region - Analysis and Forecast, 2023-2033"" report has been added to ...",CTLT,0.056011,0.197072,Somewhat-Bullish
Exclusive: Catalent's Indiana plant to make Novo's Wegovy weight-loss drug-sources,https://www.reuters.com/business/healthcare-pharmaceuticals/catalents-indiana-plant-make-novos-wegovy-weight-loss-drug-sources-2023-08-25/,2023-08-25 14:52:41,Exclusive: Catalent's Indiana plant to make ...,CTLT,0.380012,0.007957,Neutral
"Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles - Catalent  ( NYSE:CTLT ) , Novo Nordisk  ( NYSE:NVO ) ",https://www.benzinga.com/general/biotech/23/08/34041655/wegovys-massive-demand-novo-nordisk-ceo-expresses-full-confidence-in-catalent-amid-manufacturing-,2023-08-25 13:44:09,"Novo Nordisk A/S's NVO CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's CTLT capability to rectify its manufacturing issues related to its popular weight-loss drug Wegovy. Jorgensen conveyed his optimism during a Reuters Newsmaker event on Friday in response to Catalent's ...",CTLT,0.213988,0.405448,Bullish
"Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says",https://www.forbes.com/sites/roberthart/2023/08/25/weight-loss-drug-wegovy-will-launch-in-more-countries-despite-ongoing-struggles-over-stellar-demand-ceo-says/,2023-08-25 12:05:45,"Novo Nordisk's CEO said it could ""take quite some years"" for the company to meet soaring demand for the popular drug.",CTLT,0.073773,0.002038,Neutral
Novo Nordisk CEO 'confident' Catalent will overcome Wegovy production problems,https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-ceo-confident-catalent-will-overcome-wegovy-production-problems-2023-08-25/,2023-08-25 09:53:00,"[1/2] A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing Rights",CTLT,0.739411,0.186316,Somewhat-Bullish
Catalent  ( CTLT )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2140444/catalent-ctlt-to-report-q4-earnings-whats-in-the-cards,2023-08-24 16:28:00,Catalent's (CTLT) Q4 results are likely to be affected by soft segmental performances.,CTLT,0.45738,0.139936,Neutral
Why Novo Nordisk Stock Was Racing Higher on Wednesday,https://www.fool.com/investing/2023/08/23/why-novo-nordisk-stock-was-racing-higher-on-wednes/,2023-08-23 18:57:40,"When you have a hot item on the market, it's wise to ramp up production.",CTLT,0.141726,-0.072276,Neutral
"Why Thermo Fisher  ( TMO )  Stock Is Gaining Today - Novo Nordisk  ( NYSE:NVO ) , Thermo Fisher Scientific  ( NYSE:TMO ) ",https://www.benzinga.com/general/biotech/23/08/34002010/one-is-not-enough-for-famed-weight-loss-drug-novo-nordisk-taps-thermo-fisher-to-ramp-up-wegovy-pr,2023-08-23 13:37:23,"Novo Nordisk A/S NVO has reportedly enlisted the services of Thermo Fisher Scientific Inc TMO as its second contract manufacturer for its highly sought-after weight-loss drug, Wegovy. Thermo Fisher has been tasked with filling Wegovy injection pens at its production facility in Greenville, North ...",CTLT,0.246582,0.105769,Neutral
Novo hires Thermo Fisher as second manufacturer for Wegovy weight-loss drug - source,https://www.reuters.com/business/healthcare-pharmaceuticals/novo-hires-thermo-fisher-2nd-manufacturer-wegovy-weight-loss-drug-source-2023-08-23/,2023-08-23 11:42:00,"A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing Rights",CTLT,0.1331,-0.02048,Neutral
"CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/08/g33975579/catalent-alert-bragar-eagel-squire-p-c-is-investigating-catalent-inc-on-behalf-of-long-term-stockh,2023-08-22 01:00:00,"NEW YORK, Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc.",CTLT,0.651499,-0.273963,Somewhat-Bearish
Regeneron's Eylea could return to growth after nod to high-dose version- analysts,https://www.reuters.com/business/healthcare-pharmaceuticals/regenerons-eylea-could-return-growth-after-nod-high-dose-version-analysts-2023-08-21/,2023-08-21 13:41:00,"The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",CTLT,0.104683,-0.005657,Neutral
Should You Invest in the SPDR S&P Pharmaceuticals ETF  ( XPH ) ?,https://www.zacks.com/stock/news/2138470/should-you-invest-in-the-spdr-sp-pharmaceuticals-etf-xph,2023-08-21 10:20:03,Sector ETF report for ...,CTLT,0.12645,0.065869,Neutral
"Catalent, facing pressure from Elliott, had other activists in stock",https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-facing-pressure-elliott-had-other-activists-stock-2023-08-14/,2023-08-14 22:42:00,"A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman/file photo",CTLT,0.614479,0.249799,Somewhat-Bullish
"AcelRx Pharmaceuticals  ( ACRX )  Reports Q2 Loss, Tops Revenue Estimates",https://www.zacks.com/stock/news/2135347/acelrx-pharmaceuticals-acrx-reports-q2-loss-tops-revenue-estimates,2023-08-10 21:30:10,"AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of 22.64% and 216.25%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.140076,0.0,Neutral
Novo Nordisk  ( NVO )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/10/novo-nordisk-nvo-q2-2023-earnings-call-transcript/,2023-08-10 16:30:24,"NVO earnings call for the period ending June 30, 2023.",CTLT,0.004701,-0.007912,Neutral
3 Top Biotech Stocks Defying the Bear Market,https://www.fool.com/investing/2023/08/10/3-top-biotech-stocks-defying-the-bear-market/,2023-08-10 09:21:00,"Biotech is still booming, if you pick the right biotech stocks.",CTLT,0.041828,-0.016836,Neutral
"Is Novavax A Buy Or A Sell After Beating Forecasts, But Trimming Its Outlook?",https://www.investors.com/news/technology/nvax-stock-buy-now/,2023-08-09 17:13:00,"Novavax ( NVAX ) beat second-quarter sales expectations and unexpectedly reported a profit, but NVAX stock remains under pressure after the company cut its 2023 outlook. For the year, Novavax now expects $1.3 billion to $1.5 billion in sales, a decrease of $100 million from the company's ...",CTLT,0.060312,-0.226101,Somewhat-Bearish
"Fusion Pharmaceuticals Inc.  ( FUSN )  Reports Q2 Loss, Misses Revenue Estimates",https://www.zacks.com/stock/news/2133513/fusion-pharmaceuticals-inc-fusn-reports-q2-loss-misses-revenue-estimates,2023-08-08 12:15:11,"Fusion Pharmaceuticals Inc. (FUSN) delivered earnings and revenue surprises of 2.56% and 88.67%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.138464,0.0,Neutral
Rising Dividend Make Zoetis A Doggone Winner - Zoetis  ( NYSE:ZTS ) ,https://www.benzinga.com/news/earnings/23/08/33572209/rising-dividend-make-zoetis-a-doggone-winner,2023-08-04 14:54:00,"When Zoetis Inc. ZTS reports second-quarter financials next week, the market will be expecting its best revenue growth in a year and a 9% jump in profits. If history repeats, the results will be even better.",CTLT,0.050572,0.12931,Neutral
"Regeneron  ( REGN )  Q2 Earnings & Sales Top, Eylea Sales Decline",https://www.zacks.com/stock/news/2132167/regeneron-regn-q2-earnings-sales-top-eylea-sales-decline,2023-08-03 16:53:00,"Regeneron (REGN) beats earnings and sales estimates in second-quarter 2023 fueled by Dupixent. However, sales of the lead drug, Eylea, decline yet again.",CTLT,0.136629,0.062995,Neutral
Why Is Regeneron Pharmaceuticals Moving Higher Today? - Regeneron Pharmaceuticals  ( NASDAQ:REGN ) ,https://www.benzinga.com/general/biotech/23/08/33549371/why-is-regeneron-pharmaceuticals-moving-higher-today,2023-08-03 14:35:42,"Regeneron Pharmaceuticals Inc REGN earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Street estimate. Revenues increased 11% Y/Y to $3.16 billion, beating the consensus of $3.01 billion. Dupixent global net sales ( recorded by Sanofi ) increased 33% to $2.79 billion ...",CTLT,0.401331,0.484263,Bullish
"Regeneron expects FDA decision on high-dose eye drug this year, shares jump",https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-pharma-beats-quarterly-profit-estimates-2023-08-03/,2023-08-03 11:50:00,"The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File Photo",CTLT,0.122269,-0.193865,Somewhat-Bearish
Sarepta Therapeutics  ( SRPT )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/02/sarepta-therapeutics-srpt-q2-2023-earnings-call-tr/,2023-08-03 01:00:34,"SRPT earnings call for the period ending June 30, 2023.",CTLT,0.004639,0.128857,Neutral
Billionaire investor Loeb cuts bearish bets to avoid short squeezes-letter,https://www.reuters.com/markets/billionaire-investor-loeb-cuts-bearish-bets-avoid-short-squeezes-letter-2023-08-01/,2023-08-01 12:53:00,Billionaire investor Loeb cuts bearish bets to avoid short ...,CTLT,0.105141,0.0,Neutral
"7 Stocks Turn $10,000 Into $99,506 In 7 Months",https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-turn-10000-in-7-months-2023/,2023-08-01 12:00:00,"If you liked how your S&P 500 stocks did in the first half, you'll love how the second half is starting. And some individual stocks are on fire.",CTLT,0.119235,0.130626,Neutral
US FDA approves second over-the-counter opioid overdose reversal drug,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-second-over-the-counter-opioid-overdose-reversal-drug-2023-07-28/,2023-07-28 17:05:00,"July 28 ( Reuters ) - The U.S. Food and Drug Administration has approved the prescription-free sale of the second opioid overdose reversal drug, its manufacturer Harm Reduction Therapeutics said on Friday.",CTLT,0.169676,-0.309341,Somewhat-Bearish
"Novo Nordisk's Wegovy Supply Delays: FDA Uncovers Catalent Factory Lapses Violating Safety Regulations - Catalent  ( NYSE:CTLT ) , Novo Nordisk  ( NYSE:NVO ) ",https://www.benzinga.com/general/biotech/23/07/33421832/novo-nordisks-wegovy-supply-delays-fda-uncovers-catalent-factory-lapses-violating-safety-regulati,2023-07-27 16:50:28,The production facility that fills the self-injection pens for the rapidly-growing weight-loss medication Wegovy from Novo Nordisk A/S NVO has been found to have persistently violated U.S. sterile-safety regulations in recent years.,CTLT,0.7887,-0.229085,Somewhat-Bearish
Insight: Wegovy weight-loss injection factory plagued by sterile-safety failures,https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-weight-loss-injection-factory-plagued-by-sterile-safety-failures-2023-07-27/,2023-07-27 05:07:00,"LONDON, July 27 ( Reuters ) - The factory that fills the self-injection pens for booming weight-loss drug Wegovy has repeatedly breached U.S. sterile-safety rules in recent years and staff have failed to perform required quality checks, a Reuters review of regulatory documents shows.",CTLT,0.373911,-0.137526,Neutral
Regeneron Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Regeneron Pharmaceuticals  ( NASDAQ:REGN ) ,https://www.benzinga.com/pressreleases/23/07/g33376698/regeneron-pharmaceuticals-investigated-by-block-leviton-for-potential-securities-law-violations-in,2023-07-25 19:04:01,"BOSTON, July 25, 2023 ( GLOBE NEWSWIRE ) -- Block & Leviton is investigating Regeneron Pharmaceuticals, Inc. REGN for potential securities law violations. Investors who have lost money in their Regeneron Pharmaceuticals, Inc. investment should contact the firm to learn more about how they might ...",CTLT,0.098255,0.059931,Neutral
"As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion",https://www.marketwatch.com/story/as-ozempic-wegovy-frenzy-continues-morgan-stanley-lifts-forecasts-for-weight-loss-drugs-to-77-billion-8d3d8c31,2023-07-21 09:05:00,"Morgan Stanley on Friday lifted its forecast for weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.",CTLT,0.181819,0.097866,Neutral
"M&A activity of pharma CMOs will continue despite challenging borrowing environment, says GlobalData",https://www.financialexpress.com/healthcare/pharma-healthcare/ma-activity-of-pharma-cmos-will-continue-despite-challenging-borrowing-environment-says-globaldata/3179936/,2023-07-21 02:30:00,"The mergers and acquisitions ( M&A ) activity of well capitalized pharmaceutical contract manufacturing organizations ( CMOs ) is set to continue over the coming years despite a challenging borrowing environment due to rising inflation and interest rates, according to GlobalData, a leading data ...",CTLT,0.158,0.041737,Neutral
"Top Stories Thursday, July 20: Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/23/07/33304679/tesla-recalls-over-17k-evs-over-camera-seat-belt-issues-university-research-uncovers-unexpected-fluc,2023-07-20 14:09:21,"Tesla Inc TSLA has issued a recall for over 1,300 Model S, X, and Y vehicles made in 2023, citing an issue with the forward-facing front camera, and over 15,000 Model S and X vehicles for problems related to front-row seat belts.",CTLT,0.069094,0.18394,Somewhat-Bullish
The Retail Army Is VERY Bullish - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/economics/macro-economic-events/23/07/33304748/the-retail-army-is-very-bullish,2023-07-20 14:02:47,"Do with this information as you see fit: Jim Cramer said this week he doesn't see a recession in the cards for the USâ€¦ The end of Fed hikes may be on the horizon but what about their effects on the economy? According to TD, the peak impact from a rate hike occurs ~4 quarters later for GDP and ~6 ...",CTLT,0.040969,0.118955,Neutral
Activist investor Elliott takes stake in drug manufacturer Catalent - source,https://www.reuters.com/markets/deals/activist-investor-elliott-takes-stake-drug-manufacturer-catalent-source-2023-07-20/,2023-07-20 13:44:00,"LONDON, July 20 ( Reuters ) - Activist investor Elliott Investment has taken a stake in contract drugmaker Catalent ( CTLT.N ) , a source familiar with the matter told Reuters on Thursday.",CTLT,0.556298,0.12825,Neutral
Netflix's Strike Defense Is Strong. It May Have Some Cracks Anyway.,https://www.nytimes.com/2023/07/20/business/dealbook/netflix-earnings-hollywood-strike.html,2023-07-20 12:11:12,The company is best suited among media giants to cope with the Hollywood shutdown. But a lengthy strike by writers and actors will eventually cause damage.,CTLT,0.021659,0.069832,Neutral
Why Catalent  ( CTLT )  Stock Is Trading Higher Premarket Today - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/news/23/07/33297933/proxy-truces-on-the-rise-at-catalent-elliott-builds-significant-stake-calls-for-board-shake-up,2023-07-20 12:08:07,"Elliott Investment Management, an activist shareholder, has reportedly acquired a substantial stake in Catalent Inc CTLT. They are now advocating for a significant overhaul of the contract manufacturer's board.",CTLT,0.772528,0.130317,Neutral
Is First Trust Health Care AlphaDEX ETF  ( FXH )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2124252/is-first-trust-health-care-alphadex-etf-fxh-a-strong-etf-right-now,2023-07-20 10:20:09,Smart Beta ETF report for ...,CTLT,0.119532,0.067655,Neutral
Activist investor Elliott takes big stake in drugmaker Catalent - WSJ,https://www.reuters.com/markets/deals/activist-investor-elliott-takes-big-stake-drugmaker-catalent-wsj-2023-07-19/,2023-07-19 23:24:17,Activist investor Elliott takes big stake in drugmaker ...,CTLT,0.908999,0.107139,Neutral
Should You Invest in the First Trust Health Care AlphaDEX ETF  ( FXH ) ?,https://www.zacks.com/stock/news/2121063/should-you-invest-in-the-first-trust-health-care-alphadex-etf-fxh,2023-07-14 10:20:04,Sector ETF report for ...,CTLT,0.129516,0.070142,Neutral
"Credit Suisse Upgrades Thermo Fisher, Calls It Best-Of-Breed Asset - Thermo Fisher Scientific  ( NYSE:TMO ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33218944/credit-suisse-upgrades-thermo-fisher-calls-it-best-of-breed-asset,2023-07-13 18:33:01,"Credit Suisse has upgraded Thermo Fisher Scientific Inc TMO to Outperform from Neutral, with a price target of $620, citing it as the best-of-breed asset. The analyst says Thermo's stock is not often cheap. Despite improved growth opportunities, its relative multiple vs. the S&P 500 has ...",CTLT,0.137671,0.376202,Bullish
Catalent  ( CTLT )  Up 3.5% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2120038/catalent-ctlt-up-35-since-last-earnings-report-can-it-continue,2023-07-12 15:30:04,Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,CTLT,0.425541,0.031758,Neutral
Morgan Stanley hires healthcare services banker Cohen from Truist,https://www.reuters.com/business/finance/morgan-stanley-hires-healthcare-services-banker-cohen-truist-2023-07-12/,2023-07-12 15:27:00,Morgan Stanley hires healthcare services banker Cohen from ...,CTLT,0.114682,-0.088846,Neutral
"Six Stocks Turn $10,000 Into $63,503 In Six Months",https://www.investors.com/etfs-and-funds/sectors/sp500-six-stocks-turn-10000-into-in-six-months-2023/,2023-06-30 12:00:00,S&P 500: Six Stocks Turn $10000 Into $63503 In Six Months ... Investor's Business Daily ...,CTLT,0.114682,0.128345,Neutral
Catalent's  ( CTLT )  Facility Snag Linked to Regeneron's Eylea CRL,https://www.zacks.com/stock/news/2114846/catalents-ctlt-facility-snag-linked-to-regenerons-eylea-crl,2023-06-29 13:38:00,"Catalent's (CTLT) drug manufacturing facility in Indiana faces problems, which is linked to FDA's rejection of Regeneron's eye drug application. This is the latest in a string of quality control issues for Catalent.",CTLT,0.540042,-0.178227,Somewhat-Bearish
Why Catalent Stock Flopped Today,https://www.fool.com/investing/2023/06/28/why-catalent-stock-flopped-today/,2023-06-28 22:40:00,The company takes the fall for a failed drug application.,CTLT,0.657566,0.022502,Neutral
"Biopharmaceutical Analytical Testing Services Market size to grow by USD 3,449.57 million from 2022 to 2027, North America to contribute to 33% of the market growth - Technavio",https://www.prnewswire.com/news-releases/biopharmaceutical-analytical-testing-services-market-size-to-grow-by-usd-3-449-57-million-from-2022-to-2027--north-america-to-contribute-to-33-of-the-market-growth---technavio-301862707.html,2023-06-27 02:15:00,"Biopharmaceutical Analytical Testing Services Market size to grow by USD 3,449.57 million from 2022 to 2027, North ... PR ...",CTLT,0.066322,0.098238,Neutral
"ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder's Meeting held on June 23, 2023",https://www.globenewswire.com/news-release/2023/06/23/2693916/0/en/ERYTECH-announces-the-approval-of-the-merger-with-Pherecydes-and-reports-the-results-of-the-Combined-Shareholder-s-Meeting-held-on-June-23-2023.html,2023-06-23 20:30:00,"ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder's Meeting held on June 23, 2023 â€¢ All resolutions voted with a large majority according to Board of Directors recommendations",CTLT,0.031487,0.007655,Neutral
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit,https://www.globenewswire.com/news-release/2023/06/20/2691596/0/en/ERYTECH-announces-that-Akkadian-is-continuing-its-attempt-at-destabilization-with-the-filing-of-a-new-lawsuit.html,2023-06-20 20:05:00,"ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit Cambridge, MA ( U.S. ) and Lyon ( France ) , June 20, 2023 - ERYTECH Pharma ( Euronext Paris and Nasdaq: ERYP ) announces the filing of a new lawsuit by Akkadian Partners.",CTLT,0.048919,0.002996,Neutral
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit - Erytech Pharma  ( NASDAQ:ERYP ) ,https://www.benzinga.com/pressreleases/23/06/g32934389/erytech-announces-that-akkadian-is-continuing-its-attempt-at-destabilization-with-the-filing-of-a-,2023-06-20 20:05:00,"ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit Cambridge, MA ( U.S. ) and Lyon ( France ) , June 20, 2023 - ERYTECH Pharma ERYP announces the filing of a new lawsuit by Akkadian Partners.",CTLT,0.048425,0.001996,Neutral
"Top 5 Performing S&P 500 Stocks This Week: 2 Are AI Latecomers, 1 Was Nearly Sunk By Covid - SPDR Select Sector Fund - Energy Select Sector  ( ARCA:XLE ) , Catalent  ( NYSE:CTLT ) , Intel  ( NASDAQ:INTC ) , Estee Lauder Cos  ( NYSE:EL ) , Oracle  ( NYSE:ORCL ) , Carnival  ( NYSE:CCL ) , SPDR S&P 500  ( ARCA:SPY ) , Invesco S&P 500 Equal Weight ETF  ( ARCA:RSP ) ",https://www.benzinga.com/etfs/broad-u-s-equity-etfs/23/06/32900668/top-5-performing-s-p-500-stocks-this-week-2-are-ai-latecomers-1-was-nearly-sunk-by-cov,2023-06-16 20:20:22,"A positive week is coming to a close for the stock market ahead of Monday's the Juneteenth holiday, with the S&P 500 Index up about 3% on the week, marking its fifth consecutive week in the green and its best weekly performance since the end of March.",CTLT,0.126119,0.065789,Neutral
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma,https://www.benzinga.com/pressreleases/23/06/g32861335/erytech-announces-that-the-commercial-court-has-rejected-akkadians-request-to-postpone-the-vote-on,2023-06-14 18:00:00,"Cambridge, MA ( U.S. ) and Lyon ( France ) , June 14, 2023, 8:00 pm CEST - ERYTECH Pharma ( Nasdaq & Euronext: ERYP ) , announced today that the Lyon Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma.",CTLT,0.053629,0.002,Neutral
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma,https://www.globenewswire.com/news-release/2023/06/14/2688418/0/en/ERYTECH-announces-that-the-Commercial-Court-has-rejected-Akkadian-s-request-to-postpone-the-vote-on-the-merger-with-Pherecydes-Pharma.html,2023-06-14 18:00:00,ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with ...,CTLT,0.053153,0.003,Neutral
"Advanced Micro Devices To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Wednesday - Advanced Micro Devices  ( NASDAQ:AMD ) , Ballard Power Systems  ( NASDAQ:BLDP ) ",https://www.benzinga.com/news/23/06/32853786/advanced-micro-devices-to-rally-around-17-here-are-10-other-analyst-forecasts-for-wednesday,2023-06-14 12:42:12,"Raymond James cut the price target for W. P. Carey Inc. WPC from $85 to $78. Raymond James analyst RJ Milligan maintained an Outperform rating. W. P. Carey shares fell 0.3% to $70.11 in pre-market trading. Raymond James boosted the price target for Advanced Micro Devices, Inc. AMD from $110 to ...",CTLT,0.261117,-0.137488,Neutral
"Catalent 'Is Starting To Move In The Right Direction,' Analyst Says, But Cautions Lack of Visibility for FY24 - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/06/32837330/catalent-is-starting-to-move-in-the-right-direction-analyst-says-but-cautions-lack-,2023-06-13 16:51:01,"Monday, Catalent Inc CTLT announced Q3 results that it delayed twice in May. William Blair says the results were better than expected, with revenue of $1.04 billion exceeding their $952 million estimate and adjusted EBITDA of $105 million, above their $90 million target.",CTLT,0.56415,-0.082589,Neutral
"S&P 500: Cruise Lines, AI Giants Lead Monday's Winners",https://www.investors.com/news/sp-500-carnival-ai-giants-broadcom-oracle-lead-big-winners/,2023-06-12 20:24:00,"S&P 500: Carnival, AI Giants Broadcom, Oracle Lead Big Winners ... Investor's Business Daily ...",CTLT,0.311631,-0.186566,Somewhat-Bearish
Why Catalent Stock Is Trading Higher Today - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/news/23/06/32821433/why-catalent-stock-is-trading-higher-today,2023-06-12 18:12:48,"Catalent, Inc. CTLT shares are trading up Monday after the company posted mixed third-quarter financial results. What To Know: Catalent reported quarterly losses of 9 cents per share, versus the analyst consensus estimate of losses of 3 cents per share.",CTLT,0.898236,0.434754,Bullish
"Stocks making the biggest moves midday: Carnival, Nasdaq, Oracle, KeyCorp and more",https://www.cnbc.com/2023/06/12/stocks-making-the-biggest-moves-midday.html,2023-06-12 17:45:21,These are the stocks posting the largest moves midday.,CTLT,0.085022,0.020002,Neutral
"Catalent  ( CTLT )  Tops Q3 Earnings Estimates, Cuts FY23 View",https://www.zacks.com/stock/news/2107090/catalent-ctlt-tops-q3-earnings-estimates-cuts-fy23-view,2023-06-12 14:43:00,"Catalent (CTLT) records lower revenues in both segments in third-quarter fiscal 2023, resulting in overall soft performance.",CTLT,0.453099,-0.076071,Neutral
"After Delaying Earnings, Catalent Posts Larger-Than-Expected Q3 Loss Due To Production Challenges - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/news/earnings/23/06/32813173/after-delaying-earnings-catalent-posts-larger-than-expected-q3-loss-due-to-production-challenges,2023-06-12 12:55:06,"Catalent Inc CTLT announced its Q3 FY23 results after delaying it twice last month. The company reported revenue of $1.04 billion, down 19% as reported, or 17% in constant currency, beating the consensus of $952.66 million. Overall organic net revenue decreased by 19% over the same period.",CTLT,0.712594,0.139649,Neutral
"Catalent  ( CTLT )  Reports Q3 Loss, Tops Revenue Estimates",https://www.zacks.com/stock/news/2106881/catalent-ctlt-reports-q3-loss-tops-revenue-estimates,2023-06-12 12:25:03,"Catalent (CTLT) delivered earnings and revenue surprises of 30.77% and 11.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.406745,0.030617,Neutral
Catalent: Fiscal Q3 Earnings Snapshot,https://apnews.com/article/earnings-eb7c2cf7de2265ec3126235208c9e774,2023-06-12 11:13:23,"SOMERSET, N.J. ( AP ) - SOMERSET, N.J. ( AP ) - Catalent Inc. ( CTLT ) on Monday reported a loss of $227 million in its fiscal third quarter. On a per-share basis, the Somerset, New Jersey-based company said it had a loss of $1.26. Losses, adjusted for one-time gains and costs, came to 9 ...",CTLT,0.893234,-0.159158,Somewhat-Bearish
Catalent reports bigger-than-expected loss on production challenges,https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-reports-bigger-than-expected-loss-production-challenges-2023-06-12/,2023-06-12 11:09:08,"June 12 ( Reuters ) - Catalent Inc ( CTLT.N ) on Monday posted a bigger-than-expected loss for the third quarter, hurt by persistent production challenges at the contract drug manufacturer's major facilities.",CTLT,0.47672,-0.0313,Neutral
Catalent  ( CTLT )  Launches Expanded OneBio Suite to Aid Customers,https://www.zacks.com/stock/news/2106532/catalent-ctlt-launches-expanded-onebio-suite-to-aid-customers,2023-06-09 15:53:00,Catalent's (CTLT) expansion of its OneBio Suite across multiple biologic therapies is expected to aid customers in leveraging its end-to-end capabilities in these areas.,CTLT,0.404098,0.093474,Neutral
"Lifshitz Law PLLC Announces Investigations of Lumen Technologies, Inc.  ( NYSE: LUMN ) , Match Group, Inc.  ( NASDAQ: MTCH ) , Fidelity National Information Services, Inc.  ( NYSE: FIS ) , and Catalent, Inc.  ( NYSE: CTLT )  - Fidelity National Info  ( NYSE:FIS ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/06/g32766826/lifshitz-law-pllc-announces-investigations-of-lumen-technologies-inc-nyse-lumn-match-group-inc-nas,2023-06-07 19:39:55,"NEW YORK, June 07, 2023 ( GLOBE NEWSWIRE ) --",CTLT,0.255106,-0.055182,Neutral
"Gummy Supplement Market Size|Share Anticipated to Reach $48.5 billion by 2028, Growing at a CAGR of 14.5%",https://www.benzinga.com/pressreleases/23/06/g32690163/gummy-supplement-market-size-share-anticipated-to-reach-48-5-billion-by-2028-growing-at-a-cagr-of-,2023-06-02 13:15:00,"Chicago, June 02, 2023 ( GLOBE NEWSWIRE ) -- The global gummy supplement market has witnessed remarkable growth with an estimated projection to reach USD 48.5 billion by 2028, up from USD 24.6 billion in 2023, at a CAGR of 14.5% . This industry is experiencing a significant surge in demand.",CTLT,0.032736,0.0,Neutral
"Five Stocks Turn $10,000 To $44,175 In Five Months",https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-turn-10000-to-44175-in-five-months-2023/,2023-05-31 12:00:00,S&P 500: Five Stocks Turn $10000 To $44175 In Five Months ... Investor's Business Daily ...,CTLT,0.139669,0.141873,Neutral
Catalent  ( CTLT )  Expands Its Facility Capabilities in Shiga,https://www.zacks.com/stock/news/2101477/catalent-ctlt-expands-its-facility-capabilities-in-shiga,2023-05-30 15:29:00,Catalent's (CTLT) latest capability expansion is expected to boost its business in the global clinical trials space in its Clinical Supply Services network.,CTLT,0.621141,0.179731,Somewhat-Bullish
"Why US Stock Futures Signal A Modestly Higher Open Today - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/05/32591305/us-stocks-set-to-open-modestly-higher-as-debt-talks-linger-why-this-analyst-sees-headwinds-easing,2023-05-26 11:17:16,"Stocks are striving hard to hold on to the momentum imparted by Nvidia Corp. NVDA-fueled rally on Thursday, with futures pointing to a modestly higher start on Friday. As the June 1 deadline for a potential default looms large, traders may be cued to any development on the debt ceiling front.",CTLT,0.103554,0.0,Neutral
Avantor's  ( AVTR )  New Tie-Up to Improve Lab Inventory Management,https://www.zacks.com/stock/news/2098649/avantors-avtr-new-tie-up-to-improve-lab-inventory-management,2023-05-23 16:17:00,Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.,CTLT,0.115509,0.145205,Neutral
Why Catalent Stock Could Only Inch Higher Today,https://www.fool.com/investing/2023/05/22/why-catalent-stock-could-only-inch-higher-today/,2023-05-22 22:28:33,Investors shrug off an analyst's recommendation downgrade.,CTLT,0.741116,0.260522,Somewhat-Bullish
"Micron Technology, Niu Technologies And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Catalent  ( NYSE:CTLT ) , Expensify  ( NASDAQ:EXFY ) ",https://www.benzinga.com/news/23/05/32503691/micron-technology-niu-technologies-and-other-big-stocks-moving-lower-in-mondays-pre-market-session,2023-05-22 10:07:48,"SunCar Technology Group Inc. SDA shares dropped 19.2% to $6.30 in pre-market trading after jumping 90% on Friday. Expensify, Inc. EXFY fell 6.9% to $6.07 in pre-market trading. Expensify launched transactional chat for accountants. Micron Technology, Inc.",CTLT,0.47672,0.009585,Neutral
Why Shares of Catalent Were Up Friday,https://www.fool.com/investing/2023/05/19/why-shares-of-catalent-were-up-friday/,2023-05-19 17:25:20,The company announced it was delaying its third-quarter report a second time.,CTLT,0.73856,0.105641,Neutral
"Stocks making the biggest moves midday: Foot Locker, Catalent, Occidental Petroleum & more",https://www.cnbc.com/2023/05/19/stocks-making-the-biggest-moves-midday-fl-dks-ctlt-oxy-more.html,2023-05-19 16:34:24,These are the stocks posting the largest moves in midday trading.,CTLT,0.121037,0.040856,Neutral
Catalent Stock Soars: Company Cuts Annual Forecast By ~$400M Hurt By Operational Challenges - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/news/earnings/23/05/32485875/catalent-stock-soars-company-cuts-annual-forecast-by-400m-hurt-by-operational-challenges,2023-05-19 14:33:12,"Catalent Inc CTLT lowered its 2023 revenue and profit forecast, reflecting operational challenges and higher-than-expected costs and delaying its Q3 FY23 earnings release twice this month. The company expects FY23 sales of $4.25-$4.35 billion compared with its prior forecast of $4.63-$4.88 ...",CTLT,0.76676,0.186503,Somewhat-Bullish
"CI&T, Globant And Other Big Stocks Moving Higher On Friday - CI&T  ( NYSE:CINT ) , Benson Hill  ( NYSE:BHIL ) ",https://www.benzinga.com/news/23/05/32486554/ci-t-globant-and-other-big-stocks-moving-higher-on-friday,2023-05-19 14:30:43,"U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Friday. Here are some big stocks recording gains in today's session. SunCar Technology Group Inc SDA jumped 70% to $6.97 amid volatility following the recent completion of the company's combination with Goldenbridge ...",CTLT,0.306963,-0.279306,Somewhat-Bearish
Catalent cuts annual revenue forecast hurt by operational challenges,https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-cuts-annual-revenue-forecast-hurt-by-operational-challenges-2023-05-19/,2023-05-19 12:28:00,"May 19 ( Reuters ) - Catalent Inc ( CTLT.N ) cut its full-year net revenue forecast on Friday, reflecting operational challenges and higher-than-expected costs after it flagged an over $400 million hit to both its annual sales and core profit forecasts earlier this month.",CTLT,0.615462,-0.067747,Neutral
"Stocks making the biggest moves premarket: Farfetch, Deere, Applied Materials and more",https://www.cnbc.com/2023/05/19/stocks-making-the-biggest-moves-premarket-farfetch-deere-applied-materials-and-more.html,2023-05-19 12:04:47,These are the stocks posting the largest moves in premarket trading.,CTLT,0.166169,-0.074138,Neutral
"Farfetch, Catalent And Other Big Stocks Moving Higher In Friday's Pre-Market Session - Bloom Energy  ( NYSE:BE ) , Coty  ( NYSE:COTY ) ",https://www.benzinga.com/news/23/05/32482222/farfetch-catalent-and-other-big-stocks-moving-higher-in-fridays-pre-market-session,2023-05-19 10:47:28,SunCar Technology Group Inc SDA shares climbed 43.9% to $5.90 in pre-market trading after dropping 33% on Thursday. Farfetch Limited FTCH rose 21.4% to $5.27 in pre-market trading after the company reported better-than-expected Q1 results. Bloom Energy Corporation BE shares gained 6% to $14.47 ...,CTLT,0.327366,0.393387,Bullish
"Why US Stock Futures Indicate A Higher Open Today - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/05/32482119/us-stock-futures-signal-strong-finish-to-week-on-tech-surge-analyst-sees-big-gains-for-year-on-hist,2023-05-19 10:44:28,"Stocks are riding on the momentum imparted by hopes of a speedy resolution to the debt ceiling impasse. Early Friday, stock futures pointed to a firmer start, signaling that the averages could extend the gains for a third straight session.",CTLT,0.1172,0.0,Neutral
"Deere, Foot Locker And 3 Stocks To Watch Heading Into Friday - Applied Mat  ( NASDAQ:AMAT ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/news/earnings/23/05/32481389/deere-foot-locker-and-3-stocks-to-watch-heading-into-friday,2023-05-19 09:17:52,"Wall Street expects Deere & Company DE to post quarterly earnings at $8.59 per share on revenue of $14.83 billion before the opening bell. Deere shares rose 1% to $374.21 in after-hours trading. Applied Materials, Inc. AMAT reported better-than-expected earnings and sales results for its second ...",CTLT,0.535653,0.406686,Bullish
Catalent Likely To Report Sharp Decline In Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/news/earnings/23/05/32480987/catalent-likely-to-report-sharp-decline-in-q3-earnings-heres-a-look-at-recent-price-target-changes-,2023-05-19 08:09:16,"Catalent, Inc. CTLT is expected to report its results for the third quarter of fiscal year 2023 before the opening bell on May 19, 2023. Analysts expect the company to post quarterly earnings at 33 cents per share, down sharply from year-ago earnings of $1.04 per share.",CTLT,0.431065,0.353931,Bullish
"Investor Sentiment Improves Further After Nasdaq Jumps 1.5% - Deere  ( NYSE:DE ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/news/earnings/23/05/32480680/investor-sentiment-improves-further-after-nasdaq-jumps-1-5,2023-05-19 06:34:52,The CNN Money Fear and Greed index showed further improvement in overall sentiment among U.S. investors on Thursday. The Nasdaq Composite surged to record its highest closing level since Aug. 2022 on Thursday amid debt ceiling negotiations that remained in focus for Wall Street traders..,CTLT,0.368773,0.0,Neutral
Looking At Catalent's Recent Unusual Options Activity - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/markets/options/23/05/32475163/looking-at-catalents-recent-unusual-options-activity,2023-05-18 20:01:38,"A whale with a lot of money to spend has taken a noticeably bearish stance on Catalent. Looking at options history for Catalent CTLT we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 15% of the investors opened trades with bullish ...",CTLT,0.841002,0.150121,Somewhat-Bullish
Psychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary - Incannex Healthcare  ( NASDAQ:IXHL ) ,https://www.benzinga.com/markets/cannabis/23/05/32432133/psychedelic-therapies-soon-available-in-australia-via-incannex-healthcare-and-subsidiary,2023-05-16 20:10:35,"Biotech giant Incannex Healthcare Ltd IXHL shared a business presentation of its newly formed psychedelic-assisted therapies subsidiary company, Psychennex Pty Ltd.",CTLT,0.080458,0.097674,Neutral
Is First Trust Health Care AlphaDEX ETF  ( FXH )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2095603/is-first-trust-health-care-alphadex-etf-fxh-a-strong-etf-right-now,2023-05-16 10:20:06,Smart Beta ETF report for ...,CTLT,0.116631,0.061379,Neutral
"Lyra Therapeutics, Inc.  ( LYRA )  Reports Q1 Loss, Tops Revenue Estimates",https://www.zacks.com/stock/news/2094585/lyra-therapeutics-inc-lyra-reports-q1-loss-tops-revenue-estimates,2023-05-12 12:15:06,"Lyra Therapeutics, Inc. (LYRA) delivered earnings and revenue surprises of -22.22% and 28.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.136888,0.0,Neutral
Catalent Unusual Options Activity - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/markets/options/23/05/32348176/catalent-unusual-options-activity,2023-05-11 17:32:33,"Someone with a lot of money to spend has taken a bullish stance on Catalent CTLT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",CTLT,0.798255,0.437083,Bullish
"Century Therapeutics, Inc.  ( IPSC )  Reports Q1 Loss, Lags Revenue Estimates",https://www.zacks.com/stock/news/2094072/century-therapeutics-inc-ipsc-reports-q1-loss-lags-revenue-estimates,2023-05-11 12:55:07,"Century Therapeutics, Inc. (IPSC) delivered earnings and revenue surprises of 0% and 23.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.138863,0.0,Neutral
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights,https://www.globenewswire.com/news-release/2023/05/11/2666557/0/en/Passage-Bio-Reports-First-Quarter-2023-Financial-Results-and-Provides-Recent-Business-Highlights.html,2023-05-11 11:00:00,"PHILADELPHIA, May 11, 2023 ( GLOBE NEWSWIRE ) -- Passage Bio, Inc. ( Nasdaq: PASG ) , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system ( CNS ) disorders, today reported financial results for the first quarter ended March 31, ...",CTLT,0.061315,0.093072,Neutral
Should You Invest in the First Trust Health Care AlphaDEX ETF  ( FXH ) ?,https://www.zacks.com/stock/news/2093125/should-you-invest-in-the-first-trust-health-care-alphadex-etf-fxh,2023-05-10 10:20:07,Sector ETF report for ...,CTLT,0.134968,0.071604,Neutral
Why Catalent Stock Was in the Red Again Today,https://www.fool.com/investing/2023/05/09/why-catalent-stock-was-in-the-red-again-today/,2023-05-09 22:36:38,The out-of-favor contract drug manufacturer saw two analysts get notably less bullish on its future.,CTLT,0.718897,0.152197,Somewhat-Bullish
"TRC Amends Its Tender Offer for Catalent, Inc.",https://www.benzinga.com/pressreleases/23/05/g32287549/trc-amends-its-tender-offer-for-catalent-inc,2023-05-09 13:00:00,"TORONTO, May 09, 2023 ( GLOBE NEWSWIRE ) -- TRC Capital Investment Corporation ( TRC ) announced today that in view of recent disclosure by Catalent, Inc. ( the ""Company"" ) , TRC has amended the terms of its tender offer for up to 2,000,000 common shares of the Company and has decreased the ...",CTLT,0.109455,0.139043,Neutral
Catalent  ( CTLT )  to Report Q3 Earnings: What's in the Cards?  ( Revised ) ,https://www.zacks.com/stock/news/2092089/catalent-ctlt-to-report-q3-earnings-whats-in-the-cards-revised,2023-05-09 10:45:00,Catalent's (CTLT) Q3 results are likely to have been driven by robust segmental performances.,CTLT,0.636698,0.214393,Somewhat-Bullish
"S&P Settles Almost Flat; Market Volatility Drops - NVIDIA  ( NASDAQ:NVDA ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/news/earnings/23/05/32281532/s-p-settles-almost-flat-market-volatility-drops,2023-05-09 10:02:14,"The S&P 500 closed mostly flat on Monday after recording sharp gains in the previous session ahead of key inflation readings this week. Shares of Catalent, Inc. CTLT dropped more than 25% on Monday after the company announced it will be delaying the release of its Q3 results.",CTLT,0.320974,0.101688,Neutral
"Nifty to cross 18,300 or bears to grip D-St? Check 9 things to know before share market opens | The Financial Express",https://www.financialexpress.com/market/nifty-to-cross-18300-or-bears-to-grip-d-st-check-9-things-to-know-before-share-market-opens/3079512/,2023-05-09 02:19:04,Nifty to cross 18300 or bears to grip D-St? Check 9 things to know ... The Financial Express ...,CTLT,0.06179,-0.092491,Neutral
Why Catalent Stock Was a Disaster Today,https://www.fool.com/investing/2023/05/08/why-catalent-stock-was-a-disaster-today/,2023-05-08 21:27:54,It's rarely good news when a company puts off releasing financial results.,CTLT,0.776097,0.07603,Neutral
"S&P 500 Stocks: Chip Giant Is Big Winner, Surging Above Early Entry",https://www.investors.com/news/sp-500-stocks-carnival-amd-are-big-winners-today/,2023-05-08 20:22:00,"S&P 500 Stocks: Carnival, AMD Are Big Winners Today | Investor's ... Investor's Business Daily ...",CTLT,0.340915,-0.558736,Bearish
"Nasdaq Edges Higher; Six Flags Reports Upbeat Results - Catalent  ( NYSE:CTLT ) , Bellicum Pharmaceuticals  ( NASDAQ:BLCM ) ",https://www.benzinga.com/news/earnings/23/05/32271374/nasdaq-edges-higher-six-flags-reports-upbeat-results,2023-05-08 18:39:02,"U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite turning higher later during the session on Monday. The Dow traded down 0.20% to 33,606.80 while the NASDAQ rose 0.14% to 12,252.53. The S&P 500, also rose, gaining, 0.04% to 4,138.09.",CTLT,0.132368,0.056912,Neutral
Why Wall Street Took a Hit From These 2 NYSE Stocks,https://www.fool.com/investing/2023/05/08/why-wall-street-took-a-hit-from-these-2-nyse-stock/,2023-05-08 16:43:00,Monday's big losers are weighing on market sentiment.,CTLT,0.554365,-0.013678,Neutral
"Stocks making the biggest moves midday: Berkshire Hathaway, Catalent, Tyson Foods, Zscaler and more",https://www.cnbc.com/2023/05/08/stocks-making-the-biggest-moves-midday-brka-ctlt-tsn-zs.html,2023-05-08 16:35:19,These are the stocks posting the largest moves in midday trading.,CTLT,0.117486,-0.071703,Neutral
"Crude Oil Rises Over 2%; US Wholesale Inventories Unchanged For March - Catalent  ( NYSE:CTLT ) , Bellicum Pharmaceuticals  ( NASDAQ:BLCM ) ",https://www.benzinga.com/news/earnings/23/05/32268494/crude-oil-rises-over-2-us-wholesale-inventories-unchanged-for-march,2023-05-08 16:04:19,"U.S. stocks traded slightly lower midway through trading, with the Nasdaq Composite dropping around 20 points on Monday. The Dow traded down 0.14% to 33,626.85 while the NASDAQ fell 0.18% to 12,212.88. The S&P 500, also fell, dropping, 0.02% to 4,135.53. Energy shares jumped by 1.1% on Monday.",CTLT,0.139669,0.058597,Neutral
Catalent  ( CTLT )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2091677/catalent-ctlt-to-report-q3-earnings-whats-in-the-cards,2023-05-08 15:52:00,Catalent's (CTLT) Q3 results are likely to have been driven by robust segmental performances.,CTLT,0.612033,0.209949,Somewhat-Bullish
Stock Market Indexes Pause Ahead Of Inflation Numbers. Buffett's Berkshire Not Interested Full Ownership Of OXY.,https://www.investors.com/market-trend/stock-market-today/stock-market-indexes-pause-ahead-of-inflation-numbers-buffetts-berkshires-not-interested-in-full-ownership-of-oxy/,2023-05-08 14:59:00,Stock Market Off Lows Ahead Of Inflation Report. Analyst Warns ... Investor's Business Daily ...,CTLT,0.07887,-0.283672,Somewhat-Bearish
"US Stocks Edge Lower; Tyson Foods Posts Q2 Loss - Catalent  ( NYSE:CTLT ) , Delek US Hldgs  ( NYSE:DK ) ",https://www.benzinga.com/news/earnings/23/05/32265745/us-stocks-edge-lower-tyson-foods-posts-q2-loss,2023-05-08 14:11:37,"U.S. stocks traded slightly lower this morning, with the Dow Jones dropping around 40 points on Monday. Following the market opening Monday, the Dow traded down 0.12% to 33,635.06 while the NASDAQ fell 0.35% to 12,191.99. The S&P 500, also fell, dropping, 0.11% to 4,131.81.",CTLT,0.138066,0.05822,Neutral
"Catalent says to cut 2023 revenue forecast, delays Q3 results",https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-say-cut-2023-revenue-forecast-delays-q3-results-2023-05-08/,2023-05-08 12:33:33,"May 8 ( Reuters ) - Contract drug manufacturer Catalent Inc ( CTLT.N ) said on Monday that it expects to ""significantly"" reduce its 2023 forecasts for revenue and core profit, and also delay releasing its third-quarter results by a week. Shares of the company fell about 20% before the bell.",CTLT,0.539306,-0.043176,Neutral
"Lyell Immunopharma  ( LYEL )  Reports Q1 Loss, Lags Revenue Estimates",https://www.zacks.com/stock/news/2090566/lyell-immunopharma-lyel-reports-q1-loss-lags-revenue-estimates,2023-05-04 23:25:11,"Lyell Immunopharma (LYEL) delivered earnings and revenue surprises of 3.57% and 97.40%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.138066,0.0,Neutral
"Biopharmaceuticals Contract Manufacturing Market to Surge at 9% CAGR, Propelled by Rising Prevalence of Chronic Diseases and Outsourcing Trend, Reveals New Report.",https://markets.businessinsider.com/news/stocks/biopharmaceuticals-contract-manufacturing-market-to-surge-at-9-cagr-propelled-by-rising-prevalence-of-chronic-diseases-and-outsourcing-trend-reveals-new-report-1032286875,2023-05-03 14:25:15,"Biopharmaceuticals Contract Manufacturing Market By Source ( Mammalian, Non-mammalian ) , By Service ( Process Development [Downstream, Upstream], Fill & Finish Operations, Analytical & QC Studies, Packaging ) , By Product, By Therapeutic Area, By Region Forecast to 2032",CTLT,0.043108,0.123591,Neutral
Is It Time to Buy the S&P 500's 3 Worst-Performing April Stocks?,https://www.fool.com/investing/2023/05/03/time-to-buy-sp-500-3-worst-performing-stocks-april/,2023-05-03 09:31:00,"The answer is yes, no, or maybe, depending on the company in question.",CTLT,0.124378,-0.151372,Somewhat-Bearish
Sarepta Therapeutics  ( SRPT )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/03/sarepta-therapeutics-srpt-q1-2023-earnings-call-tr/,2023-05-03 04:00:25,"SRPT earnings call for the period ending March 31, 2023.",CTLT,0.029821,0.153875,Somewhat-Bullish
"4 Stocks Turn $10,000 Into $50,000 In Four Months",https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-turn-10000-into-in-four-months-2023/,2023-05-01 12:00:00,S&P 500: 4 Stocks Turn $10000 Into $50000 In Four Months ... Investor's Business Daily ...,CTLT,0.15347,0.150204,Somewhat-Bullish
Catalent  ( CTLT )  Stock Jumps 6.8%: Will It Continue to Soar?,https://www.zacks.com/stock/news/2087247/catalent-ctlt-stock-jumps-68-will-it-continue-to-soar,2023-05-01 05:54:00,Catalent (CTLT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.,CTLT,0.610896,0.106992,Neutral
"Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion - Awakn Life Sciences  ( OTC:AWKNF ) ",https://www.benzinga.com/markets/cannabis/23/04/32087706/awakns-q4-2023-and-annual-financials-500-yoy-revenue-increase-following-network-expansion,2023-04-28 16:57:29,"The UK-based psychedelics biotech company Awakn Life Sciences Corp. AWKNF reported on its financial results and business highlights for the three and twelve months ended Jan. 31, 2023.",CTLT,0.081276,0.044746,Neutral
Catalent Unusual Options Activity For April 28 - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/markets/options/23/04/32086812/catalent-unusual-options-activity-for-april-28,2023-04-28 15:32:32,"Someone with a lot of money to spend has taken a bullish stance on Catalent CTLT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",CTLT,0.795859,0.436638,Bullish
Will BioCryst Pharmaceuticals  ( BCRX )  Report Negative Earnings Next Week? What You Should Know,https://www.zacks.com/stock/news/2085068/will-biocryst-pharmaceuticals-bcrx-report-negative-earnings-next-week-what-you-should-know,2023-04-26 14:02:10,BioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,CTLT,0.175539,-0.001428,Neutral
Why Catalent Stock Tumbled by Nearly 6% on Tuesday,https://www.fool.com/investing/2023/04/25/why-catalent-stock-tumbled-by-nearly-6-on-tuesday/,2023-04-25 21:11:31,A warning about revenue and the abandonment of a potential suitor are recent developments that continue to hammer sentiment on the company.,CTLT,0.538389,-0.114529,Neutral
These 2 Large-Cap Laggards Are Leading Markets Lower Tuesday,https://www.fool.com/investing/2023/04/25/these-2-large-cap-laggards-are-leading-markets-low/,2023-04-25 16:53:00,Investors worry that an economic recession could hit entire swaths of the stock market hard.,CTLT,0.064797,0.076481,Neutral
"CTLT FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Alerts Catalent  ( CTLT )  Investors to Today's Deadline in Securities Fraud Class Action - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31994266/ctlt-final-deadline-alert-hagens-berman-national-trial-attorneys-alerts-catalent-ctlt-investors-to,2023-04-25 16:44:53,"SAN FRANCISCO, April 25, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Catalent, Inc. CTLT investors who suffered substantial losses submit your losses now. Class Period: Aug. 30, 2021- Oct. 31, 2022Lead Plaintiff Deadline: Apr. 25, 2023Visit: https://www.hbsslaw.com/investor-fraud/CTLT ...",CTLT,0.672533,-0.234777,Somewhat-Bearish
Earnings Preview: Catalent  ( CTLT )  Q3 Earnings Expected to Decline,https://www.zacks.com/stock/news/2084208/earnings-preview-catalent-ctlt-q3-earnings-expected-to-decline,2023-04-25 14:01:28,Catalent (CTLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,CTLT,0.259267,-0.015951,Neutral
"Declining COVID-19 Revenues Impact Danaher's Q1 Earnings, Lowers Annual Guidance - Danaher  ( NYSE:DHR ) ",https://www.benzinga.com/news/earnings/23/04/31983591/why-danaher-shares-are-falling-today,2023-04-25 13:17:13,"Danaher Corp ( NYSE: DHR ) has logged Q1 FY23 adjusted EPS of $2.36, down from $2.76 a year ago, surpassing the consensus of $2.25. Sales decreased 7% Y/Y to $7.17 billion, beating the consensus of $7.02 billion, with a 4% non-GAAP core revenue decrease, due to lower COVID-19 revenue and 6.0% ...",CTLT,0.306963,0.196555,Somewhat-Bullish
"eBay To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday - Advanced Micro Devices  ( NASDAQ:AMD ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/04/31985463/ebay-to-rally-around-30-here-are-10-other-analyst-forecasts-for-tuesday,2023-04-25 11:53:56,"B of A Securities cut the price target for Catalent, Inc. CTLT from $78 to $49. B of A Securities analyst Derik De Bruin maintained a Neutral rating. Catalent shares fell 0.2% to $44.83 in pre-market trading. Canaccord Genuity cut the price target for Tenable Holdings, Inc. TENB from $56 to $53.",CTLT,0.291182,-0.195096,Somewhat-Bearish
"CTLT LAWSUIT ALERT: Levi & Korsinsky Reminds Catalent, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31966795/ctlt-lawsuit-alert-levi-korsinsky-reminds-catalent-inc-investors-of-a-class-action-lawsuit-and-upc,2023-04-24 18:50:09,"NEW YORK, April 24, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT of a class action securities lawsuit.",CTLT,0.712594,-0.243397,Somewhat-Bearish
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalent, Inc. - CTLT",https://www.benzinga.com/pressreleases/23/04/g31959993/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-catalent-inc-ct,2023-04-24 15:24:56,"NEW YORK, April 24, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",CTLT,0.66906,-0.323048,Somewhat-Bearish
"CTLT FINAL DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important April 25 Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31947928/ctlt-final-deadline-alert-rosen-a-leading-national-firm-encourages-catalent-inc-investors-with-los,2023-04-22 16:35:00,"NEW YORK, April 22, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ""Class Period"" ) , of the important April 25, 2023, lead ...",CTLT,0.394125,-0.074741,Neutral
"CATALENT DEADLINE ALERT: Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Catalent To Contact Him Directly To Discuss Their Options",https://www.prnewswire.com/news-releases/catalent-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-100-000-in-catalent-to-contact-him-directly-to-discuss-their-options-301804679.html,2023-04-22 11:00:00,CATALENT DEADLINE ALERT: Securities Litigation Partner James ... PR ...,CTLT,0.695767,-0.073133,Neutral
"CATALENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Catalent, Inc. and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31946522/catalent-deadline-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-,2023-04-22 01:00:00,"NEW YORK, April 21, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT in the United States District Court for the ...",CTLT,0.674418,-0.056858,Neutral
Catalent Unusual Options Activity For April 21 - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/markets/options/23/04/31943278/catalent-unusual-options-activity-for-april-21,2023-04-21 20:15:52,"Someone with a lot of money to spend has taken a bearish stance on Catalent CTLT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",CTLT,0.795859,0.286543,Somewhat-Bullish
"Catalent, Inc.: Please contact the Portnoy Law Firm to recover your losses; April 25, 2023 deadline - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31925247/catalent-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-april-25-2023-deadline,2023-04-20 20:38:22,Investors can contact the law firm at no cost to learn more about recovering their losses,CTLT,0.774013,-0.314839,Somewhat-Bearish
This Is What Whales Are Betting On Catalent - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/markets/options/23/04/31925045/this-is-what-whales-are-betting-on-catalent,2023-04-20 20:31:25,"Someone with a lot of money to spend has taken a bullish stance on Catalent CTLT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",CTLT,0.795859,0.436638,Bullish
"SHAREHOLDER ALERT: The Gross Law Firm Reminds Shareholders of Catalent, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2023 -  ( NYSE: CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31920892/shareholder-alert-the-gross-law-firm-reminds-shareholders-of-catalent-inc-of-a-class-action-lawsui,2023-04-20 17:23:00,"NEW YORK, April 20, 2023 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Catalent, Inc.. Shareholders who purchased shares of CTLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.",CTLT,0.613743,-0.164567,Somewhat-Bearish
"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Catalent  ( CTLT )  Investors with Substantial Losses to Contact Firm's Attorneys Before Apr. 25th Deadline, CFO Departs - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31919559/hagens-berman-national-trial-attorneys-encourages-catalent-ctlt-investors-with-substantial-losses-,2023-04-20 16:17:00,"SAN FRANCISCO, April 20, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Catalent, Inc. CTLT investors who suffered substantial losses submit your losses now.",CTLT,0.672533,-0.231175,Somewhat-Bearish
"CTLT ALERT: The Klein Law Firm Reminds Investors of a Lead Plaintiff Deadline of April 25, 2023 in the Class Action Filed on Behalf of Catalent, Inc. Shareholders - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31895956/ctlt-alert-the-klein-law-firm-reminds-investors-of-a-lead-plaintiff-deadline-of-april-25-2023-in-t,2023-04-19 16:15:30,"NEW YORK, April 19, 2023 ( GLOBE NEWSWIRE ) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Catalent, Inc. CTLT alleging that the Company violated federal securities laws.",CTLT,0.82082,-0.211737,Somewhat-Bearish
"CATALENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31878048/catalent-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-reminds-invest,2023-04-19 02:33:43,"NEW ORLEANS, April 18, 2023 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( ""KSF"" ) and KSF partner, former Attorney General of Louisiana, Charles C.",CTLT,0.533842,0.275303,Somewhat-Bullish
Why Catalent Stock Dove More Than 7% Today,https://www.fool.com/investing/2023/04/18/why-catalent-stock-dove-more-than-7-today/,2023-04-18 22:33:03,The specialty healthcare company is having a miserable couple of days on the exchange.,CTLT,0.70749,-0.023432,Neutral
Dow Jones Fades As Goldman Sachs Earnings Drop; These 3 Bill Ackman Stocks Are Near Buy Points,https://www.investors.com/market-trend/stock-market-today/dow-jones-up-as-goldman-sachs-earnings-drop-these-bill-ackman-stocks-are-near-buy-points-netflix-earnings-nflx-stock/,2023-04-18 19:14:00,Dow Jones Fades As Goldman Sachs Earnings Drop. These 3 Bill ... Investor's Business Daily ...,CTLT,0.088964,-0.328229,Somewhat-Bearish
"Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Catalent, Inc.  ( CTLT )  - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31866647/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-04-18 18:27:23,"LOS ANGELES, April 18, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming April 25, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Catalent, Inc. ( ""Catalent"" or ...",CTLT,0.630514,-0.091699,Neutral
Catalent  ( CTLT )  Declines on Profit Warnings and CFO Exit,https://www.zacks.com/stock/news/2080674/catalent-ctlt-declines-on-profit-warnings-and-cfo-exit,2023-04-18 17:55:00,Catalent (CTLT) issues a profit warning for third-quarter fiscal 2023 amid supply chain disruptions and operational challenges. It also announces the departure of its CFO.,CTLT,0.735092,0.446747,Bullish
"Soon After Operational Inefficiencies, Danaher's Takeover Interest Of Catalent Takes Backseat - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/news/large-cap/23/04/31856556/why-catalent-shares-are-falling-today,2023-04-18 13:52:15,Life-sciences company Danaher Corporation DHR is reportedly no longer considering a takeover of contract manufacturer Catalent Inc CTLT after expressing interest in buying the company earlier this year.,CTLT,0.801457,-0.012247,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, Tesla, DLocal, and Cognyte and Encourages Investors to Contact the Firm - Cognyte Software  ( NASDAQ:CGNT ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31845057/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-catal,2023-04-18 01:00:00,"NEW YORK, April 17, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Catalent, Inc. CTLT, Tesla, Inc. TSLA, DLocal Ltd DLO, and Cognyte Software Ltd.",CTLT,0.295207,-0.04433,Neutral
Why Catalent Stock Slumped on Monday,https://www.fool.com/investing/2023/04/17/why-catalent-stock-slumped-on-monday/,2023-04-17 21:51:40,It looks like the company won't be acquired after all...at least for now.,CTLT,0.70749,-0.11134,Neutral
Earnings Season Picks Up Steam,https://www.forbes.com/sites/jjkinahan/2023/04/17/earnings-season-picks-up-steam/,2023-04-17 13:27:58,It was a quiet week for stocks with both the S&P 500 and Nasdaq Composite both up less than 1%.,CTLT,0.121959,0.084242,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalent, Inc. - CTLT",https://www.benzinga.com/pressreleases/23/04/g31821676/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-catalent-inc-ct,2023-04-16 19:28:13,"NEW YORK, April 16, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",CTLT,0.66906,-0.323048,Somewhat-Bearish
StockNews.com Upgrades Catalent to Sell Rating: Implications for Investors and Market Value,https://beststocks.com/stocknews-com-upgrades-catalent-to-sell-rating-im/,2023-04-15 22:15:33,StockNews.com Upgrades Catalent to Sell Rating: Implications for ... Best Stocks ...,CTLT,0.3796,0.202871,Somewhat-Bullish
"Catalent, Inc.: Please contact the Portnoy Law Firm to recover your losses; April 25, 2023 deadline - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31816179/catalent-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-april-25-2023-deadline,2023-04-14 23:18:27,"LOS ANGELES, April 14, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Catalent, Inc ( ""Catalent"" or ""the Company"" ) CTLT investors that a lawsuit filed on behalf of investors that purchased Catalent securities CTLT between August 30, 2021 to October 31, 2022 ( the ""Class Period"" ) .",CTLT,0.797189,-0.318255,Somewhat-Bearish
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalent, Inc. - CTLT",https://markets.businessinsider.com/news/stocks/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-catalent-inc.-ctlt-1032155065,2023-04-14 18:04:00,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalent, Inc. ...",CTLT,0.666827,-0.322578,Somewhat-Bearish
Stock Market Losses Steepen; Banks Kick Off Earnings Season,https://www.investors.com/market-trend/stock-market-today/stock-market-losses-steepen-banks-kick-off-earnings-season/,2023-04-14 17:54:00,Stock Market Remains Lower. Banks Kick Off Earnings But Can't Lift ... Investor's Business Daily ...,CTLT,0.117774,-0.243953,Somewhat-Bearish
Why Catalent  ( CTLT )  Stock Is Plunging Today - Catalent  ( NYSE:CTLT ) ,https://www.benzinga.com/news/earnings/23/04/31809406/catalents-operational-inefficiencies-analyst-downgrades-stock-seeks-additional-clarity,2023-04-14 16:17:34,"Catalent Inc CTLT announced the departure of its CFO, Thomas Castellano. Search for another CFO is underway. Ricky Hopson, the company's President, Division Head for Clinical Development & Supply, is appointed Interim CFO.",CTLT,0.690822,0.325201,Somewhat-Bullish
Drug manufacturer Catalent's stock tumbles 25% after profit warning and CFO departure,https://www.marketwatch.com/story/catalent-issues-profit-warning-for-fiscal-q3-after-manufacturing-and-cost-issues-at-three-plants-sending-stock-down-20-120d0af5,2023-04-14 14:57:00,Drug manufacturer Catalent said higher-than-expected costs and productivity issues at three plants would have a material adverse impact on fiscal third-quarter earnings.,CTLT,0.585334,-0.076393,Neutral
Catalent Issued a Profit Warning. The Stock Is S&P 500's Leading Decliner.,https://www.barrons.com/articles/catalent-stock-s-p-500-leading-decliner-a2557907,2023-04-14 14:10:00,Catalent Issues Profit Warning. The Stock Is S&P 500's Leading Decliner. ...,CTLT,0.651499,0.067159,Neutral
"Bronstein, Gewirtz & Grossman, LLC Notifies Catalent, Inc.  ( CTLT )  Investors of Class Action and to Actively Participate - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31806917/bronstein-gewirtz-grossman-llc-notifies-catalent-inc-ctlt-investors-of-class-action-and-to-activel,2023-04-14 14:00:00,"NEW YORK, April 14, 2023 ( GLOBE NEWSWIRE ) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Catalent, Inc. ( ""Catalent"" or ""the Company"" ) CTLT and certain of its officers, on behalf of all persons and entities ...",CTLT,0.693563,-0.193077,Somewhat-Bearish
"US Stocks Mixed; Retail Sales Drop 1% In March - CXApp  ( NASDAQ:CXAI ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/news/earnings/23/04/31806716/us-stocks-mixed-retail-sales-drop-1-in-march,2023-04-14 13:50:02,"U.S. stocks traded mixed this morning, following the release of economic reports. Following the market opening Friday, the Dow traded up 0.08% to 34,055.40 while the NASDAQ fell 0.10% to 12,153.84. The S&P 500, also rose, gaining, 0.13% to 4,151.57. Financials shares rose by 1.2% on Friday.",CTLT,0.143415,0.00632,Neutral
"Contract drug manufacturer Catalent warns of hit from costs, low production",https://www.reuters.com/business/healthcare-pharmaceuticals/contract-drug-manufacturer-catalent-warns-hit-fourth-quarter-results-2023-04-14/,2023-04-14 11:43:00,Contract drug manufacturer Catalent warns of hit to fourth-quarter ... ...,CTLT,0.688096,-0.234812,Somewhat-Bearish
"ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important April 25 Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31799200/rosen-a-globally-respected-law-firm-encourages-catalent-inc-investors-with-losses-to-secure-counse,2023-04-13 21:52:00,"NEW YORK, April 13, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ""Class Period"" ) , of the important April 25, 2023, lead ...",CTLT,0.231884,0.179007,Somewhat-Bullish
Sarepta shares drop as report says FDA almost rejected under-review gene therapy,https://www.reuters.com/business/healthcare-pharmaceuticals/sarepta-shares-drop-report-says-fda-almost-rejected-under-review-gene-therapy-2023-04-13/,2023-04-13 13:29:44,Sarepta shares drop as report says FDA almost rejected under ... ...,CTLT,0.227007,-0.069547,Neutral
"S&P 500 Futures Climb in Premarket Trading; Sarepta Therapeutics, Catalent Lag",https://www.barrons.com/articles/s-p-500-futures-climb-in-premarket-trading-sarepta-therapeutics-catalent-lag-93f56907,2023-04-13 11:30:00,"S&P 500 Futures Climb in Premarket Trading. Sarepta Therapeutics, Catalent Lag ...",CTLT,0.798255,0.029125,Neutral
"FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31781104/filing-deadline-kuznicki-law-pllc-announces-class-action-on-behalf-of-shareholders-of-catalent-inc,2023-04-13 02:19:33,"CEDARHURST, N.Y., April 12, 2023 ( GLOBE NEWSWIRE ) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Catalent, Inc. ( the ""Company"" ) CTLT, if they purchased the Company's securities between August 30, 2021 and October 31, 2022, inclusive ( the ...",CTLT,0.404563,0.197239,Somewhat-Bullish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inspirato, Kornit, Alico, and Catalent and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/04/g31780745/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-inspi,2023-04-13 01:00:00,"NEW YORK, April 12, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Inspirato Incorporated ISPO, Kornit Digital Ltd. KRNT, Alico, Inc.",CTLT,0.344644,-0.042508,Neutral
Here's Why You Should Retain Catalent  ( CTLT )  Stock for Now,https://www.zacks.com/stock/news/2077367/heres-why-you-should-retain-catalent-ctlt-stock-for-now,2023-04-12 11:27:00,"Catalent's (CTLT) product and service launches, and a slew of strategic deals raise optimism about the stock.",CTLT,0.543004,0.355477,Bullish
"CATALENT SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31760761/catalent-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-,2023-04-12 01:42:27,"NEW ORLEANS, April 11, 2023 ( GLOBE NEWSWIRE ) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2023 to file lead plaintiff applications in a securities class action lawsuit against Catalent, Inc. ( the ""Company"" ) CTLT, if they purchased ...",CTLT,0.636698,0.321877,Somewhat-Bullish
Alcami Appoints Vice President of Marketing,https://www.prnewswire.com/news-releases/alcami-appoints-vice-president-of-marketing-301793529.html,2023-04-10 19:17:00,"WILMINGTON, N.C., April 10, 2023 /PRNewswire/ -- Alcami Corporation ( ""Alcami"" ) , a leading contract development and manufacturing organization ( CDMO ) , announced today the appointment of Jessica Cao to Vice President of Marketing.",CTLT,0.12165,0.029025,Neutral
"CTLT LAWSUIT ALERT: Levi & Korsinsky Notifies Catalent, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31731808/ctlt-lawsuit-alert-levi-korsinsky-notifies-catalent-inc-investors-of-a-class-action-lawsuit-and-up,2023-04-10 18:23:13,"NEW YORK, April 10, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT of a class action securities lawsuit.",CTLT,0.712594,-0.243397,Somewhat-Bearish
"DEADLINE ALERT for KRNT, ISPO, ALCO, and CTLT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/04/g31729527/deadline-alert-for-krnt-ispo-alco-and-ctlt-the-law-offices-of-frank-r-cruz-reminds-investors-of-cl,2023-04-10 16:04:33,"LOS ANGELES, April 10, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",CTLT,0.160633,-0.224019,Somewhat-Bearish
"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Catalent  ( CTLT )  Investors with Substantial Losses to Contact Firm's Attorneys, Securities Fraud Class Action Pending - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31725881/hagens-berman-national-trial-attorneys-encourages-catalent-ctlt-investors-with-substantial-losses-,2023-04-10 13:18:00,"SAN FRANCISCO, April 10, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Catalent, Inc. CTLT investors who suffered substantial losses submit your losses now.",CTLT,0.620858,-0.174331,Somewhat-Bearish
"Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday - Clene  ( NASDAQ:CLNN ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/news/23/04/31724728/valero-energy-to-rally-32-here-are-10-other-analyst-forecasts-for-monday,2023-04-10 12:32:13,Credit Suisse boosted the price target for The Boeing Company BA from $200 to $220. Credit Suisse analyst Scott Deuschle maintained a Neutral rating on the stock. Boeing shares fell 0.4% to $210.60 in pre-market trading. Raymond James boosted the price target for Valero Energy Corporation VLO ...,CTLT,0.276909,0.395993,Bullish
Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size to Exceed $55.3 Billion by 2030 with 6.3% CAGR,https://www.benzinga.com/pressreleases/23/04/g31721731/global-pharmaceutical-solid-dosage-contract-manufacturing-market-size-to-exceed-55-3-billion-by-20,2023-04-10 08:09:46,"Washington, DC, April 10, 2023 ( GLOBE NEWSWIRE ) -- Zion Market Research has published a new research report titled ""Pharmaceutical Solid Dosage Contract Manufacturing Market By Product Type ( Tablets, Capsule, Lozenge, Powder, And Others ) , By Drug Releases Pattern ( Instant Release, ...",CTLT,0.086059,0.12343,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT",https://www.benzinga.com/pressreleases/23/04/g31719203/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-catalent-inc-ct,2023-04-08 21:30:15,"NEW YORK, April 08, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",CTLT,0.66906,-0.323048,Somewhat-Bearish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inspirato, Kornit, Alico, and Catalent and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/04/g31716202/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-inspi,2023-04-08 01:00:00,"NEW YORK, April 07, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Inspirato Incorporated ISPO, Kornit Digital Ltd. KRNT, Alico, Inc.",CTLT,0.344815,-0.049964,Neutral
"ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Catalent, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31714373/rosen-a-global-and-leading-law-firm-encourages-catalent-inc-investors-to-secure-counsel-before-imp,2023-04-07 18:41:00,"NEW YORK, April 07, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ""Class Period"" ) , of the important April 25, 2023, lead ...",CTLT,0.231884,0.189801,Somewhat-Bullish
"CATALENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31672497/catalent-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-reminds-invest,2023-04-05 02:42:00,"NEW ORLEANS, April 04, 2023 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( ""KSF"" ) and KSF partner, former Attorney General of Louisiana, Charles C.",CTLT,0.533842,0.275303,Somewhat-Bullish
"DEADLINE ALERT for KRNT, ISPO, ALCO, and CTLT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/04/g31661228/deadline-alert-for-krnt-ispo-alco-and-ctlt-the-law-offices-of-frank-r-cruz-reminds-investors-of-cl,2023-04-04 16:00:00,"LOS ANGELES, April 04, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",CTLT,0.160633,-0.224019,Somewhat-Bearish
S&P 500's Biggest Loser Monday Is One Of 2023's Top Performers,https://www.investors.com/news/tesla-is-sp-500s-biggest-loser-monday-as-oil-stocks-dominate-upside/,2023-04-03 20:36:00,2023 Big Winners S&P 500's Big Loser Monday Investor's Business Daily ...,CTLT,0.296761,-0.024265,Neutral
"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Catalent  ( CTLT )  Investors with Substantial Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class Action - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31636628/hagens-berman-national-trial-attorneys-encourages-catalent-ctlt-investors-with-substantial-losses-,2023-04-03 15:09:11,"SAN FRANCISCO, April 03, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Catalent, Inc. CTLT investors who suffered substantial losses submit your losses now. Class Period: Aug. 30, 2021- Oct. 31, 2022Lead Plaintiff Deadline: Apr. 25, 2023Visit: https://www.hbsslaw.com/investor-fraud/CTLT ...",CTLT,0.654522,-0.167485,Somewhat-Bearish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kornit, Alico, Catalent, and Tesla and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/04/g31625098/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-korni,2023-04-03 01:00:00,"NEW YORK, April 02, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kornit Digital Ltd. KRNT, Alico, Inc. ALCO, Catalent, Inc. CTLT, and Tesla, Inc.",CTLT,0.28648,-0.043294,Neutral
"ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/04/g31624347/rosen-recognized-investor-counsel-encourages-catalent-inc-investors-with-losses-to-secure-counsel-,2023-04-02 17:05:00,"NEW YORK, April 02, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ""Class Period"" ) , of the important April 25, 2023, lead ...",CTLT,0.231884,0.179007,Somewhat-Bullish
"Three Stocks Turn $10,000 To $25,265 In Just 3 Months",https://www.investors.com/etfs-and-funds/sectors/sp500-three-stocks-turn-10000-just-3-months-2023/,2023-03-31 11:30:00,S&P 500: Three Stocks Turn $10000 To $25265 In Just 3 Months ... Investor's Business Daily ...,CTLT,0.142565,0.14358,Neutral
"Catalent  ( CTLT )  New Launch to Aid TPD Programs, Clinical Trials",https://www.zacks.com/stock/news/2072593/catalent-ctlt-new-launch-to-aid-tpd-programs-clinical-trials,2023-03-30 16:34:00,Catalent's (CTLT) latest launch will likely aid in advancing the rational selection of orally developable TPD candidates and their progress into clinical trials.,CTLT,0.541149,0.104859,Neutral
"FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31569445/filing-deadline-kuznicki-law-pllc-announces-class-action-on-behalf-of-shareholders-of-catalent-inc,2023-03-30 02:50:00,"CEDARHURST, N.Y., March 29, 2023 ( GLOBE NEWSWIRE ) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Catalent, Inc. ( the ""Company"" ) CTLT, if they purchased the Company's securities between August 30, 2021 and October 31, 2022, inclusive ( the ...",CTLT,0.404563,0.197239,Somewhat-Bullish
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalent, Inc. - CTLT",https://www.benzinga.com/pressreleases/23/03/g31566831/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-catalent-inc-ct,2023-03-30 00:14:04,"NEW YORK, March 29, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",CTLT,0.66906,-0.323048,Somewhat-Bearish
"DEADLINE ALERT for KRNT, ISPO, ALCO, and CTLT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/03/g31553706/deadline-alert-for-krnt-ispo-alco-and-ctlt-the-law-offices-of-frank-r-cruz-reminds-investors-of-cl,2023-03-29 16:05:00,"LOS ANGELES, March 29, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",CTLT,0.160633,-0.224019,Somewhat-Bearish
"CATALENT SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31541687/catalent-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-,2023-03-29 02:31:25,"NEW ORLEANS, March 28, 2023 ( GLOBE NEWSWIRE ) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2023 to file lead plaintiff applications in a securities class action lawsuit against Catalent, Inc. ( the ""Company"" ) CTLT, if they purchased ...",CTLT,0.636698,0.321877,Somewhat-Bullish
"Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Catalent, Inc.  ( CTLT )  - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31531908/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-03-28 14:30:00,"LOS ANGELES, March 28, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming April 25, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Catalent, Inc. ( ""Catalent"" or ...",CTLT,0.630514,-0.091699,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, Tesla, DLocal, and Cognyte and Encourages Investors to Contact the Firm - Cognyte Software  ( NASDAQ:CGNT ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31522689/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-catal,2023-03-28 01:00:00,"NEW YORK, March 27, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Catalent, Inc. CTLT, Tesla, Inc. TSLA, DLocal Ltd DLO, and Cognyte Software Ltd.",CTLT,0.295076,-0.037718,Neutral
"ROSEN, A TOP RANKED LAW FIRM, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31520803/rosen-a-top-ranked-law-firm-encourages-catalent-inc-investors-with-losses-to-secure-counsel-before,2023-03-27 21:07:00,"NEW YORK, March 27, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ""Class Period"" ) , of the important April 25, 2023, lead ...",CTLT,0.231884,0.189801,Somewhat-Bullish
"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Catalent  ( CTLT )  Investors with Substantial Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class Action - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31513132/hagens-berman-national-trial-attorneys-encourages-catalent-ctlt-investors-with-substantial-losses-,2023-03-27 14:24:35,"SAN FRANCISCO, March 27, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Catalent, Inc. CTLT investors who suffered substantial losses submit your losses now. Class Period: Aug. 30, 2021- Oct. 31, 2022Lead Plaintiff Deadline: Apr. 25, 2023Visit: https://www.hbsslaw.com/investor-fraud/CTLT ...",CTLT,0.654522,-0.167485,Somewhat-Bearish
"DEADLINE ALERT for CTLT, BROS, CGNT, LUMN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Cognyte Software  ( NASDAQ:CGNT ) , Dutch Bros  ( NYSE:BROS ) ",https://www.benzinga.com/pressreleases/23/03/g31511124/deadline-alert-for-ctlt-bros-cgnt-lumn-law-offices-of-howard-g-smith-reminds-investors-of-class-ac,2023-03-27 13:00:00,"BENSALEM, Pa., March 27, 2023 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",CTLT,0.29176,-0.208411,Somewhat-Bearish
"2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch",https://www.fool.com/investing/2023/03/25/2-clinical-research-stocks-that-could-grow-by-more/,2023-03-25 11:20:00,These companies strive to bring down the cost of developing new therapies.,CTLT,0.16709,0.216189,Somewhat-Bullish
"Lifshitz Law PLLC Announces Investigations of Dutch Bros, Inc.  ( NYSE: BROS ) , Tesla, Inc.  ( NASDAQ: TSLA ) , Catalent, Inc.  ( NYSE: CTLT ) , and Alico, Inc.  ( NASDAQ: ALCO )  - Alico  ( NASDAQ:ALCO ) , Dutch Bros  ( NYSE:BROS ) ",https://www.benzinga.com/pressreleases/23/03/g31497628/lifshitz-law-pllc-announces-investigations-of-dutch-bros-inc-nyse-bros-tesla-inc-nasdaq-tsla-catal,2023-03-24 20:00:00,"NEW YORK, March 24, 2023 ( GLOBE NEWSWIRE ) -- Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company failed to disclose to investors: ( i ) that the Company was experiencing ...",CTLT,0.251941,-0.054634,Neutral
Catalent  ( CTLT )  Inks Deal for Nasal Spray for Opioid Overdoses,https://www.zacks.com/stock/news/2070302/catalent-ctlt-inks-deal-for-nasal-spray-for-opioid-overdoses,2023-03-24 15:16:00,Catalent's (CTLT) latest commercial supply agreement is expected to combat the opioid epidemic by making OTC naloxone more widely and easily accessible.,CTLT,0.538939,0.104579,Neutral
"Bronstein, Gewirtz & Grossman, LLC Notifies Catalent, Inc.  ( CTLT )  Investors of Class Action and to Actively Participate - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31491757/bronstein-gewirtz-grossman-llc-notifies-catalent-inc-ctlt-investors-of-class-action-and-to-activel,2023-03-24 14:00:00,"NEW YORK, March 24, 2023 ( GLOBE NEWSWIRE ) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Catalent, Inc. ( ""Catalent"" or ""the Company"" ) CTLT and certain of its officers, on behalf of all persons and entities ...",CTLT,0.693563,-0.193077,Somewhat-Bearish
"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Catalent, Inc.  ( CTLT ) , and Cognyte Software Ltd.  ( CGNT ) , and PLDT Inc.  ( PHI ) , and Encourages Investors to Contact the Firm",https://www.benzinga.com/pressreleases/23/03/g31491186/investor-alert-kirby-mcinerney-llp-reminds-investors-that-securities-class-action-lawsuits-have-be,2023-03-24 13:30:00,"NEW YORK, March 24, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP reminds investors that securities class action lawsuits have been filed on behalf of investors in securities of Catalent, Inc., Cognyte Software Ltd., and PLDT, Inc.",CTLT,0.422661,-0.239266,Somewhat-Bearish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inspirato, Kornit, Alico, and Catalent and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/03/g31468317/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-inspi,2023-03-23 01:00:00,"NEW YORK, March 22, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Inspirato Incorporated ISPO, Kornit Digital Ltd. KRNT, and Alico, Inc.",CTLT,0.344644,-0.042507,Neutral
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022,https://www.globenewswire.com/news-release/2023/03/22/2632759/0/en/ERYTECH-Provides-Business-and-Financial-Update-for-the-Fourth-Quarter-and-Full-Year-2022.html,2023-03-22 21:05:00,ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year ...,CTLT,0.103598,0.007725,Neutral
"ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Catalent, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31465242/rosen-a-globally-respected-law-firm-encourages-catalent-inc-investors-with-losses-in-excess-of-100,2023-03-22 20:52:00,"NEW YORK, March 22, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ""Class Period"" ) , of the important April 25, 2023, lead ...",CTLT,0.231884,0.179007,Somewhat-Bullish
"DEADLINE ALERT for KRNT, ISPO, ALCO, and CTLT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/03/g31460115/deadline-alert-for-krnt-ispo-alco-and-ctlt-the-law-offices-of-frank-r-cruz-reminds-investors-of-cl,2023-03-22 16:05:00,"LOS ANGELES, March 22, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",CTLT,0.160633,-0.224019,Somewhat-Bearish
"CATALENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31450585/catalent-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-reminds-invest,2023-03-22 02:51:00,"NEW ORLEANS, March 21, 2023 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( ""KSF"" ) and KSF partner, former Attorney General of Louisiana, Charles C.",CTLT,0.533842,0.275303,Somewhat-Bullish
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalent, Inc. - CTLT",https://www.benzinga.com/pressreleases/23/03/g31428737/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-catalent-inc-ct,2023-03-20 20:56:21,"NEW YORK, March 20, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",CTLT,0.66906,-0.323048,Somewhat-Bearish
"PHARMACEUTICS INTERNATIONAL ONBOARDS NEW LEADERSHIP TEAM TO DRIVE QUALITY, OPERATIONAL IMPROVEMENTS, AND GROWTH",https://www.benzinga.com/pressreleases/23/03/g31424142/pharmaceutics-international-onboards-new-leadership-team-to-drive-quality-operational-improvements,2023-03-20 16:24:14,"Hunt Valley, MD, March 20, 2023 ( GLOBE NEWSWIRE ) -- HUNT VALLEY, MD., March 20, 2023",CTLT,0.033515,0.138345,Neutral
Catalent  ( CTLT )  Inks Deal for New & Effective Drug Delivery,https://www.zacks.com/stock/news/2068098/catalent-ctlt-inks-deal-for-new-effective-drug-delivery,2023-03-20 15:13:00,"Catalent (CTLT) will use Bhami Research Laboratory's technology to evaluate and develop drug-delivery system for high-concentration therapies, thereby increasing effectiveness.",CTLT,0.660375,0.501087,Bullish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, Tesla, DLocal, and Cognyte and Encourages Investors to Contact the Firm - Cognyte Software  ( NASDAQ:CGNT ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31408388/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-catal,2023-03-18 01:00:00,"NEW YORK, March 17, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Catalent, Inc. CTLT, Tesla, Inc. TSLA, DLocal Ltd DLO, and Cognyte Software Ltd.",CTLT,0.295076,-0.037718,Neutral
"Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Catalent, Inc.  ( CTLT )  - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31385857/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-03-16 17:52:02,"LOS ANGELES, March 16, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming April 25, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Catalent, Inc. ( ""Catalent"" or ...",CTLT,0.630514,-0.091699,Neutral
"ROSEN, A RESPECTED AND LEADING FIRM, Encourages Catalent, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31384110/rosen-a-respected-and-leading-firm-encourages-catalent-inc-investors-with-losses-in-excess-of-100k,2023-03-16 16:20:23,"NEW YORK, March 16, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ""Class Period"" ) , of the important April 25, 2023, lead ...",CTLT,0.231884,0.179007,Somewhat-Bullish
Zoetis  ( ZTS )  Down 6.5% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2066849/zoetis-zts-down-65-since-last-earnings-report-can-it-rebound,2023-03-16 15:30:22,Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,CTLT,0.202366,0.057587,Neutral
Catalent's  ( CTLT )  Tie-Up to Accelerate Clinical Trial Timelines,https://www.zacks.com/stock/news/2066808/catalents-ctlt-tie-up-to-accelerate-clinical-trial-timelines,2023-03-16 15:19:00,Catalent's (CTLT) latest collaboration is expected to leverage multiple services that reduce drug development timelines.,CTLT,0.57911,0.375546,Bullish
"FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31373501/filing-deadline-kuznicki-law-pllc-announces-class-action-on-behalf-of-shareholders-of-catalent-inc,2023-03-16 02:53:00,"CEDARHURST, N.Y., March 15, 2023 ( GLOBE NEWSWIRE ) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Catalent, Inc. ( the ""Company"" ) CTLT, if they purchased the Company's securities between August 30, 2021 and October 31, 2022, inclusive ( the ...",CTLT,0.404563,0.197239,Somewhat-Bullish
"Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder - Incannex Healthcare  ( NASDAQ:IXHL ) , Filament Health  ( OTC:FLHLF ) ",https://www.benzinga.com/markets/cannabis/23/03/31366219/psychedelic-trials-update-treating-meth-addiction-fibromyalgia-general-anxiety-disorder,2023-03-15 20:54:37,Three companies have provided updates on their efforts to assess different psychedelics for treating a widely varied set of conditions. Clinical-stage natural psychedelic drug developer Filament Health Corp.,CTLT,0.069094,0.059743,Neutral
"DEADLINE ALERT for KRNT, ISPO, ALCO, and CTLT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/03/g31365556/deadline-alert-for-krnt-ispo-alco-and-ctlt-the-law-offices-of-frank-r-cruz-reminds-investors-of-cl,2023-03-15 16:35:00,"LOS ANGELES, March 15, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",CTLT,0.160633,-0.224019,Somewhat-Bearish
Interim review of proprietary PsiGAD clinical trial data indicates no safety concerns and projects a statistically significant benefit for the psilocybin arm versus the placebo arm in those participants who have completed the treatment,https://www.globenewswire.com/news-release/2023/03/15/2627537/0/en/Interim-review-of-proprietary-PsiGAD-clinical-trial-data-indicates-no-safety-concerns-and-projects-a-statistically-significant-benefit-for-the-psilocybin-arm-versus-the-placebo-arm.html,2023-03-15 11:30:00,Highlights: ...,CTLT,0.029508,0.027565,Neutral
"CATALENT SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31353959/catalent-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-,2023-03-15 02:39:20,"NEW ORLEANS, March 14, 2023 ( GLOBE NEWSWIRE ) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2023 to file lead plaintiff applications in a securities class action lawsuit against Catalent, Inc. ( the ""Company"" ) CTLT, if they purchased ...",CTLT,0.636698,0.321877,Somewhat-Bullish
"Catalent, Inc.  ( CTLT )  Class Action Alert: Contact Robbins LLP Regarding Representation as Lead Plaintiff in Class Action Against Catalent, Inc. - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31326606/catalent-inc-ctlt-class-action-alert-contact-robbins-llp-regarding-representation-as-lead-plaintif,2023-03-13 17:56:06,"SAN DIEGO, March 13, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Catalent, Inc.",CTLT,0.784319,-0.036612,Neutral
"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Catalent  ( CTLT )  Investors with Substantial Losses to Contact Firm's Attorneys, Securities Fraud Class Action Pending - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31324293/hagens-berman-national-trial-attorneys-encourages-catalent-ctlt-investors-with-substantial-losses-,2023-03-13 15:56:38,"SAN FRANCISCO, March 13, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Catalent, Inc. CTLT investors who suffered substantial losses submit your losses now. Class Period: Aug. 30, 2021- Oct. 31, 2022Lead Plaintiff Deadline: Apr. 25, 2023Visit: https://www.hbsslaw.com/investor-fraud/CTLT ...",CTLT,0.654522,-0.167485,Somewhat-Bearish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Alico, Catalent, Tesla, and DLocal and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/03/g31312346/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-alico,2023-03-13 01:00:00,"NEW YORK, March 12, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Alico, Inc. ALCO, Catalent, Inc. CTLT, Tesla, Inc.",CTLT,0.320279,-0.047237,Neutral
"ROSEN, A TOP RANKED LAW FIRM, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31309240/rosen-a-top-ranked-law-firm-encourages-catalent-inc-investors-with-losses-to-secure-counsel-before,2023-03-11 20:51:00,"WHY: NEW YORK, March 11, 2023 ( GLOBE NEWSWIRE ) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ""Class Period"" ) , of the important April 25, 2023, lead ...",CTLT,0.231884,0.179007,Somewhat-Bullish
5 Best ETFs Tracking CRISPR Gene Editing,https://www.fool.com/investing/stock-market/market-sectors/healthcare/genomics-stocks/crispr-etfs/,2023-03-10 20:45:33,These exchange-traded funds track companies in this biotech space.,CTLT,0.130926,0.065929,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalent, Inc. - CTLT",https://www.benzinga.com/pressreleases/23/03/g31302660/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-catalent-inc-ct,2023-03-10 20:25:08,"NEW YORK, March 10, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",CTLT,0.66906,-0.323048,Somewhat-Bearish
What's Next For Catalent Stock After A 50% Rise This Year?,https://www.forbes.com/sites/greatspeculations/2023/03/10/whats-next-for-catalent-stock-after-a-50-rise-this-year/,2023-03-10 14:00:00,"After a 54% rise year-to-date, at the current levels, Catalent stock (NYSE: CTLT), a global solutions provider for drugs, biologics, gene therapies, and consumer healthcare products, has little room for growth, in our view.",CTLT,0.762722,0.245734,Somewhat-Bullish
"DEADLINE ALERT for KRNT, ISPO, ALCO, and CTLT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/03/g31282048/deadline-alert-for-krnt-ispo-alco-and-ctlt-the-law-offices-of-frank-r-cruz-reminds-investors-of-cl,2023-03-09 17:35:00,"LOS ANGELES, March 09, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",CTLT,0.160633,-0.224019,Somewhat-Bearish
Here's Why You Should Retain Catalent  ( CTLT )  Stock for Now,https://www.zacks.com/stock/news/2063629/heres-why-you-should-retain-catalent-ctlt-stock-for-now,2023-03-09 15:15:00,Catalent's (CTLT) product and service launches and a slew of strategic deals raise optimism about the stock.,CTLT,0.441912,0.26814,Somewhat-Bullish
"CATALENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31251565/catalent-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-reminds-invest,2023-03-08 03:03:20,"NEW ORLEANS, March 07, 2023 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( ""KSF"" ) and KSF partner, former Attorney General of Louisiana, Charles C.",CTLT,0.539306,0.276845,Somewhat-Bullish
"Catalent, Inc.  ( CTLT )  Class Action Notice: Contact Robbins LLP for Information Regarding Class Action Against Catalent, Inc. - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31245603/catalent-inc-ctlt-class-action-notice-contact-robbins-llp-for-information-regarding-class-action-a,2023-03-07 20:22:18,"SAN DIEGO, March 07, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Catalent, Inc.",CTLT,0.784319,-0.036586,Neutral
"Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More - Awakn Life Sciences  ( OTC:AWKNF ) , Algernon Pharmaceuticals  ( OTC:AGNPF ) ",https://www.benzinga.com/markets/cannabis/23/03/31224750/psyched-9-us-reform-bills-ayahuasca-a-release-for-prince-harry-at-home-therapy-more,2023-03-07 15:29:18,"Throughout the 2023 session, numerous discussions have been held and various measures have been considered around the legalization of psychedelics. Let's go over the latest proposed regulations.",CTLT,0.0553,0.087848,Neutral
"CTLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Catalent, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31239144/ctlt-investor-alert-robbins-geller-rudman-dowd-llp-announces-that-catalent-inc-investors-with-subs,2023-03-07 14:49:05,"SAN DIEGO, March 07, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Catalent, Inc.",CTLT,0.855019,-0.137977,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Alico, Catalent, Tesla, and DLocal and Encourages Investors to Contact the Firm - Catalent  ( NYSE:CTLT ) , Alico  ( NASDAQ:ALCO ) ",https://www.benzinga.com/pressreleases/23/03/g31230089/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-alico,2023-03-07 02:00:00,"NEW YORK, March 06, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Alico, Inc. ALCO, Catalent, Inc. CTLT, Tesla, Inc.",CTLT,0.320279,-0.047237,Neutral
"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Catalent, Inc.  ( CTLT )  Investors and Encourages Investors to Contact the Firm Before April 25, 2023 - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31229472/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-cata,2023-03-07 00:09:53,"NEW YORK, March 06, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.",CTLT,0.746902,-0.106495,Neutral
"CTLT CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Catalent  ( CTLT )  Investors with Substantial Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31225316/ctlt-class-action-hagens-berman-national-trial-attorneys-encourages-catalent-ctlt-investors-with-s,2023-03-06 20:42:56,"SAN FRANCISCO, March 06, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Catalent, Inc. CTLT investors who suffered substantial losses submit your losses now. Class Period: Aug. 30, 2021- Oct. 31, 2022Lead Plaintiff Deadline: Apr. 25, 2023Visit: https://www.hbsslaw.com/investor-fraud/CTLT ...",CTLT,0.654522,-0.167485,Somewhat-Bearish
"Bronstein, Gewirtz & Grossman, LLC Notifies Catalent, Inc.  ( CTLT )  Investors of Class Action and to Actively Participate - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31195001/bronstein-gewirtz-grossman-llc-notifies-catalent-inc-ctlt-investors-of-class-action-and-to-activel,2023-03-03 16:09:00,"NEW YORK, March 03, 2023 ( GLOBE NEWSWIRE ) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Catalent, Inc. ( ""Catalent"" or ""the Company"" ) CTLT and certain of its officers, on behalf of all persons and entities ...",CTLT,0.693563,-0.193077,Somewhat-Bearish
"Incannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials - Incannex Healthcare  ( NASDAQ:IXHL ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/markets/cannabis/23/03/31192834/incannex-engages-catalent-for-development-and-manufacture-of-psilocybin-drug-for-clinical-trials,2023-03-03 14:27:55,"Incannex Healthcare Limited IXHL IHL, a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic medicine therapies for unmet medical needs, has engaged Catalent CTLT to develop and manufacture a cGMP-grade psilocybin drug product for: use in Incannex's ...",CTLT,0.366061,0.112446,Neutral
Incannex Engages Catalent for Development and cGMP Manufacture of Psilocybin Drug Product for Clinical Trials and Potential Commercial Use,https://www.globenewswire.com/news-release/2023/03/03/2620152/0/en/Incannex-Engages-Catalent-for-Development-and-cGMP-Manufacture-of-Psilocybin-Drug-Product-for-Clinical-Trials-and-Potential-Commercial-Use.html,2023-03-03 12:30:00,Highlights: ...,CTLT,0.290607,0.104563,Neutral
Biologics CDMO market size to increase by USD 13.26 billion from 2022 to 2027: Strong research and development pipeline of biologics therapeutics to boost market growth - Technavio,https://www.prnewswire.com/news-releases/biologics-cdmo-market-size-to-increase-by-usd-13-26-billion-from-2022-to-2027-strong-research-and-development-pipeline-of-biologics-therapeutics-to-boost-market-growth---technavio-301759648.html,2023-03-02 22:05:00,Biologics CDMO market size to increase by USD 13.26 billion from ... PR ...,CTLT,0.040622,0.038595,Neutral
"Catalent, Inc.: Please contact the Portnoy Law Firm to recover your losses; April 25, 2023 deadline - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31180831/catalent-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-april-25-2023-deadline,2023-03-02 20:40:35,Investors can contact the law firm at no cost to learn more about recovering their losses,CTLT,0.774013,-0.314839,Somewhat-Bearish
"FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31152481/filing-deadline-kuznicki-law-pllc-announces-class-action-on-behalf-of-shareholders-of-catalent-inc,2023-03-02 03:37:05,"CEDARHURST, N.Y., March 01, 2023 ( GLOBE NEWSWIRE ) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Catalent, Inc. ( the ""Company"" ) CTLT, if they purchased the Company's securities between August 30, 2021 and October 31, 2022, inclusive ( the ...",CTLT,0.404563,0.197239,Somewhat-Bullish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, and Tesla and Encourages Investors to Contact the Firm",https://www.barrons.com/articles/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-catalent-and-tesla-and-encourages-investors-to-contact-the-firm-4bf5343b,2023-03-02 02:46:54,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, and Tesla and Encourages Investors to Contact the Firm",CTLT,0.853391,0.141705,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, and Tesla and Encourages Investors to Contact the Firm - Tesla  ( NASDAQ:TSLA ) , Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31150609/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-catal,2023-03-02 02:00:00,"NEW YORK, March 01, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Catalent, Inc. CTLT, and Tesla, Inc.",CTLT,0.477986,-0.053305,Neutral
"CTLT EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/03/g31136967/ctlt-equity-alert-rosen-trusted-investor-counsel-encourages-catalent-inc-investors-with-losses-to-,2023-03-01 19:24:21,"NEW YORK, March 01, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Catalent, Inc. CTLT between August 30, 2021 and October 31, 2022, both dates inclusive ( the ...",CTLT,0.232996,0.116105,Neutral
"Softgel Capsules Market Size to Surpass USD 9.59 Billion by 2027, With 5.5% CAGR | Analysis by Fortune Business Insights",https://www.benzinga.com/pressreleases/23/03/g31116715/softgel-capsules-market-size-to-surpass-usd-9-59-billion-by-2027-with-5-5-cagr-analysis-by-fortune,2023-03-01 11:26:20,"Pune, India, March 01, 2023 ( GLOBE NEWSWIRE ) -- The global softgel capsules market size was valued at USD 6.52 Billion in 2020. The market is projected to grow from USD 6.94 billion in 2021 to USD 9.59 Billion in 2027, exhibiting a CAGR of 5.5% during the forecast period.",CTLT,0.088309,0.036041,Neutral
"CATALENT SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/02/g31111748/catalent-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-,2023-03-01 04:06:20,"NEW ORLEANS, Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2023 to file lead plaintiff applications in a securities class action lawsuit against Catalent, Inc. ( the ""Company"" ) CTLT, if they purchased ...",CTLT,0.636698,0.321877,Somewhat-Bullish
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalent, Inc. - CTLT",https://www.benzinga.com/pressreleases/23/02/g31111249/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-catalent-inc-ct,2023-03-01 02:52:06,"NEW YORK, Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ( ""Catalent"" or the ""Company"" ) CTLT. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",CTLT,0.66906,-0.323048,Somewhat-Bearish
Sarepta Therapeutics  ( SRPT )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/28/sarepta-therapeutics-srpt-q4-2022-earnings-call-tr/,2023-03-01 02:30:32,"SRPT earnings call for the period ending December 31, 2022.",CTLT,0.023923,0.120132,Neutral
"Two S&P 500 Stocks Turn $10,000 To $19,631 In Just 2 Months",https://www.investors.com/etfs-and-funds/sectors/sp-500-stocks-turn-10000-to-19631-in-just-2-months-2023/,2023-02-28 13:00:00,Two S&P 500 Stocks Turn $10000 To $19631 In Just 2 Months Investor's Business Daily ...,CTLT,0.615462,0.217834,Somewhat-Bullish
"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Catalent  ( CTLT )  Investors with Substantial Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/02/g31082086/hagens-berman-national-trial-attorneys-encourages-catalent-ctlt-investors-with-substantial-losses-,2023-02-28 02:09:21,"SAN FRANCISCO, Feb. 27, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Catalent, Inc. CTLT investors who suffered substantial losses submit your losses now. Class Period: Aug. 30, 2021- Oct. 31, 2022Lead Plaintiff Deadline: Apr. 25, 2023Visit: https://www.hbsslaw.com/investor-fraud/CTLT ...",CTLT,0.654522,-0.167485,Somewhat-Bearish
"Catalent, Inc.  ( CTLT )  Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Catalent, Inc. - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/pressreleases/23/02/g31080684/catalent-inc-ctlt-shareholder-alert-robbins-llp-reminds-investors-of-class-action-against-catalent,2023-02-27 23:04:41,"SAN DIEGO, Feb. 27, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Catalent, Inc.",CTLT,0.784319,-0.036586,Neutral
Biologics Development and Manufacturing Testing Technologies and Global Market Research Report 2023,https://www.prnewswire.com/news-releases/biologics-development-and-manufacturing-testing-technologies-and-global-market-research-report-2023-301754793.html,2023-02-24 00:30:00,Biologics Development and Manufacturing Testing Technologies ... PR ...,CTLT,0.03545,0.140351,Neutral
Got $300? 3 Growth Stocks to Buy That Could Double Your Money,https://www.fool.com/investing/2023/02/21/got-300-growth-stocks-buy-could-double-your-money/,2023-02-21 10:16:00,All three companies have shown consistent revenue and EPS growth.,CTLT,0.038906,0.087853,Neutral
These Are The Best  ( And Worst )  Performing Stocks Of 2023,https://www.forbes.com/sites/dereksaul/2023/02/20/these-are-the-best-and-worst-performing-stocks-of-2023/,2023-02-20 16:24:32,Tesla's 69% surge leads the charge.,CTLT,0.075635,0.021414,Neutral
"Fish Oil Market 2023 Demand, Global Trends, Analysis and Forecast till 2030 | Fortune Business Insightsâ„¢",https://www.benzinga.com/pressreleases/23/02/g30976650/fish-oil-market-2023-demand-global-trends-analysis-and-forecast-till-2030-fortune-business-insight,2023-02-20 13:50:39,"Pune, India, Feb. 20, 2023 ( GLOBE NEWSWIRE ) -- According to a report by Fortune Business Insightsâ„¢, titled, ""Fish Oil Market Size, Share and Global Trend by Species ( Tuna, Cod Liver, Salmon, Anchovy, Menhaden, Others ) , by Application ( Aquaculture Feed, Animal Feed, Functional Food, Dietary ...",CTLT,0.07913,0.155721,Somewhat-Bullish
These money and investing tips can build your portfolio's offense and defense,https://www.marketwatch.com/story/these-money-and-investing-tips-can-build-your-portfolios-offense-and-defense-e7bfb278,2023-02-11 20:09:00,Money and investing stories popular with MarketWatch readers over the past week.,CTLT,0.08183,0.0,Neutral
Why Catalent Stock Was on Fire This Week,https://www.fool.com/investing/2023/02/10/why-catalent-stock-was-on-fire-this-week/,2023-02-10 23:49:13,The shares did exceptionally well considering the company had a ho-hum quarter.,CTLT,0.689185,0.280655,Somewhat-Bullish
"Stock Market Week: Gold, Lithium, Steel, And Deere, Medpace Earnings",https://www.investors.com/research/investing-action-plan/stock-market-week-gold-lithium-steel-and-deere-medpace-earnings/,2023-02-10 23:03:00,"Stock Market Week: Gold, Lithium, Steel, And Deere, Medpace ... Investor's Business Daily ...",CTLT,0.04045,0.02854,Neutral
The stock market rally of 2023 has surprised even Wall Street veterans. Here are the 10 best-performers on the S&P 500 and what could be driving them.,https://markets.businessinsider.com/news/stocks/stocks-best-performers-sp500-us-rally-drive-surprise-gains-2023-2,2023-02-10 12:57:48,10 Best-Performing Stocks on the S&P 500 and What Could Be ... - Markets Insider ...,CTLT,0.139669,0.0391,Neutral
A New Way Of Delivering MDMA? Awakn And Tech Partner Are Set To Study Viability - Awakn Life Sciences  ( OTC:AWKNF ) ,https://www.benzinga.com/markets/cannabis/23/02/30842251/a-new-way-of-delivering-mdma-awakn-and-tech-partner-are-set-to-study-viability,2023-02-09 21:56:03,"Psychedelics biotech Awakn Life Sciences AWKNF has initiated a feasibility study of formulating and delivering MDMA through Catalent's proprietary oral, fast-dissolving tablet Zydis technology.",CTLT,0.151539,0.30023,Somewhat-Bullish
"Watch the stock market closely now. If the S&P 500 breaks below 4100, the next stop could be 7% lower.",https://www.marketwatch.com/story/watch-the-stock-market-closely-now-if-the-s-p-500-breaks-below-4100-the-next-stop-could-be-7-lower-11675966135,2023-02-09 18:08:00,Buyers are running out of wiggle room.,CTLT,0.062191,-0.046092,Neutral
Biggest gainers of S&P 500: Year to date performance | The Financial Express,https://www.financialexpress.com/investing-abroad/featured-stories/biggest-gainers-of-sampp-500-year-to-date-performance/2976819/,2023-02-09 12:02:00,Biggest gainers of S&P 500: Year to date performance The Financial Express ...,CTLT,0.109455,0.054105,Neutral
Exelixis  ( EXEL )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/08/exelixis-exel-q4-2022-earnings-call-transcript/,2023-02-08 06:00:34,"EXEL earnings call for the period ending December 31, 2022.",CTLT,0.006821,0.042697,Neutral
Stock Market Warms Up To Powell's Comments; Indexes Finish Strong,https://www.investors.com/market-trend/stock-market-today/stock-market-whipsaws-after-powells-comments-its-probably-going-to-be-bumpy/,2023-02-07 21:20:00,Stock Market Whipsaws After Powell's Comments. No Real ... Investor's Business Daily ...,CTLT,0.12165,0.136092,Neutral
"Compared to Estimates, Catalent  ( CTLT )  Q2 Earnings: A Look at Key Metrics",https://www.zacks.com/stock/news/2051073/compared-to-estimates-catalent-ctlt-q2-earnings-a-look-at-key-metrics,2023-02-07 16:06:00,"Although the revenue and EPS for Catalent (CTLT) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",CTLT,0.561184,-0.016735,Neutral
Catalent  ( CTLT )  Surges on Rumors of Acquisition by Danaher,https://www.zacks.com/stock/news/2051034/catalent-ctlt-surges-on-rumors-of-acquisition-by-danaher,2023-02-07 15:09:00,"Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.",CTLT,0.823139,0.509577,Bullish
"Catalent  ( CTLT )  Q2 Earnings Lag Estimates, Revenues Top",https://www.zacks.com/stock/news/2051030/catalent-ctlt-q2-earnings-lag-estimates-revenues-top,2023-02-07 15:07:00,"Catalent (CTLT) records lower revenues in both segments in its second-quarter fiscal 2023, resulting in overall soft performance.",CTLT,0.411549,0.005697,Neutral
"Catalent, Inc. Reports Second Quarter Fiscal 2023 Results",https://www.barrons.com/articles/catalent-inc-reports-second-quarter-fiscal-2023-results-01675771447,2023-02-07 14:01:46,"Catalent, Inc. ( NYSE: CTLT ) , the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced financial results for the second quarter of fiscal 2023, which ended ...",CTLT,0.900719,0.218315,Somewhat-Bullish
Deals Are Creeping Back. Don't Expect a Surge Just Yet.,https://www.barrons.com/articles/deals-mergers-acquisitions-ipos-51675718714,2023-02-07 13:35:00,There have been a lot of deal headlines as of late but that hasn't meant volumes are climbing from the dismal pace at the end of last year. At least not yet.,CTLT,0.733479,0.391846,Bullish
Catalent  ( CTLT )  Misses Q2 Earnings Estimates,https://www.zacks.com/stock/news/2050812/catalent-ctlt-misses-q2-earnings-estimates,2023-02-07 13:15:04,"Catalent (CTLT) delivered earnings and revenue surprises of -6.94% and 2.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.405651,0.220088,Somewhat-Bullish
Catalent: Fiscal Q2 Earnings Snapshot,https://apnews.com/article/financial-markets-automated-insights-earnings-catalent-inc-business-0a7f31d8c9cfb98c70e0f8177ebfc0a5,2023-02-07 12:10:39,"SOMERSET, N.J. ( AP ) - SOMERSET, N.J. ( AP ) - Catalent Inc. ( CTLT ) on Tuesday reported fiscal second-quarter net income of $81 million. On a per-share basis, the Somerset, New Jersey-based company said it had net income of 44 cents. Earnings, adjusted for one-time gains and costs, came ...",CTLT,0.885652,0.146657,Neutral
Deals Are Creeping Back. Don't Expect a Surge Just Yet.,https://www.barrons.com/articles/deals-no-surge-51675718714,2023-02-07 06:00:00,There have been a lot of deal headlines as of late but that hasn't meant volumes are climbing from the dismal pace at the end of last year. At least not yet.,CTLT,0.733479,0.391846,Bullish
"Tyson Foods, Dell fall; Tesla, Life Storage rise",https://apnews.com/article/technology-dell-inc-financial-markets-life-storage-public-c8496102e3f3a55ed6ae46958f17e7f1,2023-02-06 21:26:33,"Tyson Foods, Dell fall. Tesla, Life Storage rise The Associated Press - en ...",CTLT,0.258351,0.561097,Bullish
Dow Jones Off Session Lows; Ryan Cohen Stock Nordstrom Plunges,https://www.investors.com/market-trend/stock-market-today/dow-jones-dips-paypal-stock-slumps-on-this-call-ryan-cohen-stock-nordstrom-plunges/,2023-02-06 20:18:00,Dow Jones Dips. PayPal Stock Slumps On This Call. Ryan Cohen ... Investor's Business Daily ...,CTLT,0.104911,-0.136019,Neutral
"Nasdaq Down Over 100 Points; Tyson Foods Posts Downbeat Earnings - Alset  ( NASDAQ:AEI ) , Asset Entities  ( NASDAQ:ASST ) ",https://www.benzinga.com/news/earnings/23/02/30740052/nasdaq-down-over-100-points-tyson-foods-posts-downbeat-earnings,2023-02-06 20:00:36,"U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 80 points on Monday. The Dow traded down 0.15% to 33,875.74 while the NASDAQ fell 0.88% to 11,900.97. The S&P 500 also fell, dropping, 0.59% to 4,112.13. Utilities shares rose by 0.3% on Monday.",CTLT,0.190667,0.418279,Bullish
Crude Oil Down Over 1%; Nasdaq Drops 80 Points,https://www.benzinga.com/news/earnings/23/02/30736489/crude-oil-down-over-1-nasdaq-drops-80-points,2023-02-06 17:49:26,"U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 80 points on Monday. The Dow traded down 0.21% to 33,853.11 while the NASDAQ fell 0.60% to 11,934.76. The S&P 500 also fell, dropping, 0.46% to 4,117.44. Consumer staples shares rose by 0.1% on Monday.",CTLT,0.190167,0.417574,Bullish
These 2 Stocks Are Making a Pop on Monday,https://www.fool.com/investing/2023/02/06/these-2-stocks-are-making-a-pop-on-monday/,2023-02-06 17:25:00,"Even as markets were under pressure, market participants found things to be happy about with these two companies.",CTLT,0.463192,0.201865,Somewhat-Bullish
"February Opens With M&A Bang As Gold Miners, REITS Propose $28 Billion In Deals",https://www.investors.com/news/mergers-and-acquisitions-february-opens-with-ma-bang-as-gold-miners-reits-propose-28-billion-in-deals/,2023-02-06 16:01:00,"February Opens With M&A Bang As Gold Miners, REITS Propose ... Investor's Business Daily ...",CTLT,0.183546,0.055952,Neutral
Stock Market Catches It Breath After Recent Gains; Onsemi Shows Strength,https://www.investors.com/market-trend/stock-market-today/stock-market-catches-it-breath-after-recent-gains-onsemi-shows-strength/,2023-02-06 15:54:00,Stock Market Bulls Take Profits Ahead Of Powell Speech. Onsemi ... Investor's Business Daily ...,CTLT,0.110717,0.226119,Somewhat-Bullish
A Big Medtech Merger Could Be In The Works - But Just One Stock Rocketed,https://www.investors.com/news/technology/catalent-stock-launches-as-danaher-reportedly-mulls-takevover/,2023-02-06 15:30:00,Catalent Stock Launches As Danaher Reportedly Mulls Takeover ... Investor's Business Daily ...,CTLT,0.589793,0.090197,Neutral
Stocks Slide To Start Week; Tesla Rallies After Musk Verdict,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-200-points-tesla-stock-rallies-on-musk-verdict-twitter-comments/,2023-02-06 15:14:00,Dow Jones Falls 175 Points As Tesla Stock Rallies On Musk Verdict ... Investor's Business Daily ...,CTLT,0.055751,-0.003005,Neutral
Why Earnings Season Could Be Great for Catalent  ( CTLT ) ,https://www.zacks.com/stock/news/2050274/why-earnings-season-could-be-great-for-catalent-ctlt,2023-02-06 13:50:00,Catalent (CTLT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,CTLT,0.902573,0.602717,Bullish
"Catalent, Faraday Future Intelligent Electric And Other Big Stocks Moving Lower In Monday's Pre-Market Session",https://www.benzinga.com/news/23/02/30729128/catalent-faraday-future-intelligent-electric-and-other-big-stocks-moving-lower-in-mondays-pre-market,2023-02-06 13:43:08,"U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today's pre-market trading session. SoundHound AI, Inc. SOUN shares climbed 26.6% to $3.5715 in pre-market trading after jumping 44% on Friday. Faraday Future Intelligent Electric Inc.",CTLT,0.40348,0.671293,Bullish
"Why Catalent  ( CTLT )  Shares Are Gaining Today - Catalent  ( NYSE:CTLT ) , Danaher  ( NYSE:DHR ) ",https://www.benzinga.com/news/large-cap/23/02/30724852/danaher-shows-interest-in-acquiring-catalent-valued-at-significant-premium-report,2023-02-06 12:44:40,"Danaher Corporation DHR has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc CTLT. According to the sources, the recent moves by the life science firm valued Catalent at a significant premium.",CTLT,0.939207,0.226294,Somewhat-Bullish
"Nasdaq Futures Indicate Subdued Start For Wall Street - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/02/30725104/nasdaq-futures-indicate-subdued-start-for-wall-street-jerome-powells-speech-on-tuesday-key-highligh,2023-02-06 11:45:03,Stock futures indicate major Wall Street indices are expected to open lower this week that will see a crucial speech by Federal Reserve Chair Jerome Powell at the Economic Club of Washington on Tuesday.,CTLT,0.187705,0.16071,Somewhat-Bullish
"Why PayPal And Coinbase Are Trading Lower; Here Are 20 Stocks Moving Premarket - AMC Entertainment  ( NYSE:AMC ) , C3.ai  ( NYSE:AI ) ",https://www.benzinga.com/news/23/02/30725237/why-paypal-and-coinbase-are-trading-lower-here-are-20-stocks-moving-premarket,2023-02-06 11:33:26,"Faraday Future Intelligent Electric Inc. FFIE shares surged 31.48% to $1.42 in pre-market trading. Arqit Quantum Inc. ARQQ shares rose 20.0% to $3 in pre-market trading. Catalent, Inc. CTLT rose 17.64% to $65.94 in pre-market trading after Danaher Corporation DHR hinted at a deal with the life ...",CTLT,0.19661,0.0,Neutral
Danaher interested in buying life sciences firm Catalent- Bloomberg News,https://www.reuters.com/business/danaher-interested-buying-life-sciences-firm-catalent-bloomberg-news-2023-02-04/,2023-02-04 19:27:00,Danaher interested in buying life sciences firm Catalent- Bloomberg ... ...,CTLT,0.880871,0.395956,Bullish
Catalent  ( CTLT )  to Report Q2 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2049633/catalent-ctlt-to-report-q2-earnings-whats-in-the-cards,2023-02-03 15:29:00,Catalent's (CTLT) Q2 results are likely to have been driven by robust segmental performances.,CTLT,0.56681,0.281901,Somewhat-Bullish
Catalent  ( CTLT )  Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release,https://www.zacks.com/stock/news/2047034/catalent-ctlt-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q2-release,2023-01-31 15:00:52,Catalent (CTLT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,CTLT,0.260652,0.140559,Neutral
Protara Therapeutics Announces Appointment of Patrick Fabbio as Chief Financial Officer,https://www.globenewswire.com/news-release/2023/01/30/2597487/0/en/Protara-Therapeutics-Announces-Appointment-of-Patrick-Fabbio-as-Chief-Financial-Officer.html,2023-01-30 13:00:00,"NEW YORK, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- Protara Therapeutics, Inc. ( Nasdaq: TARA ) , a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Patrick Fabbio as Chief Financial Officer effective January ...",CTLT,0.039944,0.008848,Neutral
Biologics CDMO Secondary Packaging Global Market Report 2022: Sector to Generate $3.62 Billion by 2030,https://www.prnewswire.com/news-releases/biologics-cdmo-secondary-packaging-global-market-report-2022-sector-to-generate-3-62-billion-by-2030--301732700.html,2023-01-28 11:10:00,Biologics CDMO Secondary Packaging Global Market Report 2022 ... PR ...,CTLT,0.063594,0.133117,Neutral
Cell & Gene Therapy Manufacturing Services Market worth $11.5 billion by 2027 - Exclusive Report by MarketsandMarketsâ„¢,https://www.prnewswire.com/news-releases/cell--gene-therapy-manufacturing-services-market-worth-11-5-billion-by-2027---exclusive-report-by-marketsandmarkets-301732234.html,2023-01-27 15:00:00,Cell & Gene Therapy Manufacturing Services Market worth $11.5 ... PR ...,CTLT,0.044469,0.081394,Neutral
Taro Pharmaceutical  ( TARO )  Lags Q3 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2043680/taro-pharmaceutical-taro-lags-q3-earnings-and-revenue-estimates,2023-01-24 23:55:03,"Taro (TARO) delivered earnings and revenue surprises of -78.16% and 14.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",CTLT,0.140485,0.0,Neutral
Exploring Why The Economist Named this Biotech 'One To watch' in 2023,https://www.investorideas.com/news/2023/biotech/01241Biotech-to-Watch-in-2023.asp,2023-01-24 17:41:34,Exploring Why The Economist Named this Biotech 'One To watch' in ... ...,CTLT,0.022181,0.10501,Neutral
"ADC  ( Anti-body-Drug Conjugates )  Contract Manufacturing Market Report 2022-2035 - Focus on Antibody Manufacturing, HPAPI / Cytotoxic Payload, Linker and Conjugation Manufacturing, and Fill / Finish",https://www.prnewswire.com/news-releases/adc-anti-body-drug-conjugates-contract-manufacturing-market-report-2022-2035---focus-on-antibody-manufacturing-hpapi--cytotoxic-payload-linker-and-conjugation-manufacturing-and-fill--finish-301726898.html,2023-01-22 12:50:00,ADC ( Anti-body-Drug Conjugates ) Contract Manufacturing Market ... PR ...,CTLT,0.029876,0.242256,Somewhat-Bullish
Biosimilar Contract Manufacturing Global Market Report 2022: Favorable Patient Demographics With Rise in Disease Burden Boosts Sector,https://www.benzinga.com/pressreleases/23/01/n30478718/biosimilar-contract-manufacturing-global-market-report-2022-favorable-patient-demographics-with-ri,2023-01-19 11:30:00,"DUBLIN, Jan. 19, 2023 /PRNewswire/ -- The ""Biosimilar Contract Manufacturing Market - Global Outlook & Forecast 2022-2027"" report has been added to ResearchAndMarkets.com's offering.",CTLT,0.041828,0.132591,Neutral
"Apprentice.io CEO, Angelo Stracquatanio, Invited to the Join Forbes Technology Council",https://www.benzinga.com/pressreleases/23/01/g30457112/apprentice-io-ceo-angelo-stracquatanio-invited-to-the-join-forbes-technology-council,2023-01-18 11:00:00,"JERSEY CITY, N.J., Jan. 18, 2023 ( GLOBE NEWSWIRE ) -- Angelo Stracquatanio, CEO and Co-founder of Apprentice.io, a technology company that helps pharma manufacturers get medicine to patients faster, was recently welcomed as a member of the Forbes Technology Council.",CTLT,0.058188,0.215008,Somewhat-Bullish
Catalent's  ( CTLT )  New Deal to Utilize Its Zydis ODT Technology,https://www.zacks.com/stock/news/2039730/catalents-ctlt-new-deal-to-utilize-its-zydis-odt-technology,2023-01-16 16:37:00,Catalent's (CTLT) latest development and license agreement is expected to accelerate the administration of therapeutic doses of active drugs.,CTLT,0.470894,0.19044,Somewhat-Bullish
J&J slashes production of its unpopular COVID-19 shot,https://www.foxbusiness.com/healthcare/jj-slashes-production-unpopular-covid-19-shot,2023-01-13 18:39:18,"After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand.",CTLT,0.093897,0.11407,Neutral
"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/01/30414942/johnson-johnson-cuts-production-ends-contracts-for-not-so-successful-covid-19-shot,2023-01-13 18:22:37,Johnson & Johnson JNJ has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. The FDA approved the single-dose shot in February 2021 as it carried fewer cold-chain storage requirements than other shots. J&J's initial supply was small.,CTLT,0.43789,0.39988,Bullish
News Exclusive | J&J Slashes Production of Its Unpopular Covid-19 Shot,https://www.wsj.com/articles/j-j-slashes-production-of-its-unpopular-covid-19-shot-11673624729,2023-01-13 15:45:00,"After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand ...",CTLT,0.595343,0.439896,Bullish
Michelle Quinn Named Acting General Counsel for BD,https://www.prnewswire.com/news-releases/michelle-quinn-named-acting-general-counsel-for-bd-301715096.html,2023-01-06 11:50:00,"FRANKLIN LAKES, N.J., Jan. 6, 2023 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) ( NYSE: BDX ) , a leading global medical technology company, announced today that Michelle Quinn has been named acting general counsel of BD, succeeding Samrat ( Sam ) Khichi, who has informed the company of ...",CTLT,0.107495,-0.102031,Neutral
